Nutanix (NTNX) 10-K 19 Sep 24 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Jul. 31, 2024	Aug. 31, 2024	Jan. 31, 2024
Entity Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jul. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--07-31
Entity Central Index Key	0001618732
Entity File Number	001-37883
Entity Registrant Name	NUTANIX, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0989767
Entity Address, Address Line One	1740 Technology Drive, Suite 150
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95110
City Area Code	408
Local Phone Number	216-8360
Title of 12(b) Security	Class A Common Stock, $0.000025 par value per share
Trading Symbol	NTNX
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 13.7
Entity Common Stock, Shares Outstanding (in shares)		265,214,643
Auditor Firm ID	34
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	San Jose, California
Auditor Opinion	Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Nutanix, Inc. and subsidiaries (the "Company") as of July 31, 2024 and 2023, the related consolidated statements of operations, comprehensive loss, stockholders' deficit, and cash flows, for each of the three years in the period ended July 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of July 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended July 31, 2024, in conformity with accounting principles generally accepted in the United States of America. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of July 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated September 19, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE As noted herein, certain information called for by Parts II and III is incorporated by reference to specified portions of the registrant’s definitive proxy statement to be filed in conjunction with the registrant’s 2024 annual meeting of stockholders, which is expected to be filed not later than 120 days after the registrant's fiscal year ended July 31, 2024 .

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 655,270	$ 512,929
Short-term investments	339,072	924,466
Accounts receivable, net of allowances of $733 and $772, respectively	229,796	157,251
Deferred commissions-current	159,849	120,001
Prepaid expenses and other current assets	97,307	147,087
Total current assets	1,481,294	1,861,734
Property and equipment, net	136,180	111,865
Operating lease right-of-use assets	109,133	93,554
Deferred commissions—non-current	198,962	237,990
Intangible assets, net	5,153	4,893
Goodwill	185,235	184,938
Other assets—non-current	27,961	31,941
Total assets	2,143,918	2,526,915
Current liabilities:
Accounts payable	45,066	29,928
Accrued compensation and benefits	195,602	143,679
Accrued expenses and other current liabilities	24,967	109,269
Deferred revenue—current	954,543	823,665
Operating lease liabilities—current	24,163	29,567
Total current liabilities	1,244,341	1,136,108
Deferred revenue—non-current	918,163	771,367
Operating lease liabilities—non-current	90,359	68,940
Convertible senior notes, net	570,073	1,218,165
Other liabilities-non-current	49,130	39,754
Total liabilities	2,872,066	3,234,334
Commitments and contingencies (Note 7)
Stockholders' deficit:
Preferred stock, par value of $0.000025 per share- 200,000 shares authorized as of July 31, 2023 and 2024; no shares issued and outstanding as of July 31, 2023 and 2024	0	0
Common stock, par value of $0.000025 per share-1,000,000 Class A shares authorized as of July 31, 2023 and 2024; 239,607 and 265,181 Class A shares issued and outstanding as of July 31, 2023 and 2024, respectively	7	6
Additional paid-in capital	4,118,898	3,930,668
Accumulated other comprehensive (loss) income	146	(5,171)
Accumulated deficit	(4,847,199)	(4,632,922)
Total stockholders' deficit	(728,148)	(707,419)
Total liabilities and stockholders' deficit	$ 2,143,918	$ 2,526,915

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Accounts receivable, allowance	$ 772	$ 733
Preferred stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common Class A
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	265,181,000	239,607,000
Common stock, shares outstanding (in shares)	265,181,000	239,607,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Revenue:
Total revenue		$ 2,148,816	$ 1,862,895	$ 1,580,796
Cost of revenue:
Total cost of revenue		324,112	332,187	321,156
Gross profit		1,824,704	1,530,708	1,259,640
Operating expenses:
Sales and marketing		977,286	924,696	979,075
Research and development		638,992	580,961	572,999
General and administrative		200,863	232,201	166,418
Total operating expenses		1,817,141	1,737,858	1,718,492
(Loss) income from operations		7,563	(207,150)	(458,852)
Other expense, net		(108,881)	(26,435)	(320,830)
Loss before provision for income taxes		(101,318)	(233,585)	(779,682)
Provision for income taxes		23,457	20,975	19,264
Net loss		$ (124,775)	$ (254,560)	$ (798,946)
Net loss per share attributable to Class A and Class B common stockholders-basic	[1]	$ (0.51)	$ (1.09)	$ (3.62)
Net loss per share attributable to Class A and Class B common stockholders-diluted	[1]	$ (0.51)	$ (1.09)	$ (3.62)
Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders-basic	[1]	244,743	233,247	220,529
Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders-diluted	[1]	244,743	233,247	220,529
Product
Revenue:
Total revenue		$ 1,067,948	$ 912,114	$ 757,623
Cost of revenue:
Total cost of revenue		36,441	51,107	55,602
Support, Entitlements and Other Services
Revenue:
Total revenue		1,080,868	950,781	823,173
Cost of revenue:
Total cost of revenue		$ 287,671	$ 281,080	$ 265,554
[1] Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 8 for further details.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (124,775)	$ (254,560)	$ (798,946)
Other comprehensive (loss) income, net of tax:
Change in unrealized (loss) gain on available-for-sale securities, net of tax	5,317	905	(6,068)
Comprehensive loss	$ (119,458)	$ (253,655)	$ (805,014)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Stockholders' (deficit) equity, beginning balance at Jul. 31, 2021	$ (1,020,969)	$ 5	$ 2,615,317	$ (8)	$ (3,636,283)
Stockholders' (deficit) equity, beginning balance (ASU 2020-06) at Jul. 31, 2021	(48,013)		(148,598)		100,585
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2021		214,210,000
Increase (Decrease) in Stockholders' Deficit
2026 Notes derivative liability reclassification	698,213		698,213
Issuance of common stock through employee equity incentive plans	6,480	$ 1	6,479
Issuance of common stock through employee equity incentive plans (in shares)		11,270,000
Issuance of common stock from ESPP purchase	62,633		62,633
Issuance of common stock from ESPP purchase (in shares)		2,827,000
Repurchase and retirement of common stock	(58,570)		(14,852)		(43,718)
Repurchase and retirement of common stock (in shares)		(1,369,000)
Unwinding of 2023 Notes hedges	39,880		39,880
Unwinding of 2023 Notes warrants	(18,390)		(18,390)
Stock-based compensation	343,246		343,246
Other comprehensive income (loss)	(6,068)			(6,068)
Net Income (Loss)	(798,946)				(798,946)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2022	(800,504)	$ 6	3,583,928	(6,076)	(4,378,362)
Stockholders' equity, ending balance (in shares) at Jul. 31, 2022		226,938,000
Increase (Decrease) in Stockholders' Deficit
Issuance of common stock through employee equity incentive plans	3,700		3,700
Issuance of common stock through employee equity incentive plans (in shares)		10,895,000
Issuance of common stock from ESPP purchase	41,509		41,509
Issuance of common stock from ESPP purchase (in shares)		2,187,000
Shares withheld related to net share settlement of equity awards (in Shares)		(413,000)
Shares withheld related to net share settlement of equity awards	(10,214)		(10,214)
Stock-based compensation	311,745		311,745
Other comprehensive income (loss)	905			905
Net Income (Loss)	(254,560)				(254,560)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2023	(707,419)	$ 6	3,930,668	(5,171)	(4,632,922)
Stockholders' equity, ending balance (in shares) at Jul. 31, 2023		239,607,000
Increase (Decrease) in Stockholders' Deficit
Issuance of common stock through employee equity incentive plans	4,241		4,241
Issuance of common stock through employee equity incentive plans (in shares)		12,429,000
Issuance of common stock from ESPP purchase	47,327		47,327
Issuance of common stock from ESPP purchase (in shares)		1,870,000
Shares withheld related to net share settlement of equity awards (in Shares)		(2,996,000)
Shares withheld related to net share settlement of equity awards	(161,552)		(161,552)
Repurchase and retirement of common stock	(131,139)		(41,637)		(89,502)
Repurchase and retirement of common stock (in shares)		(2,583,000)
Issuance of common stock related to conversion of 2026 Notes	6,019	$ 1	6,018
Issuance of common stock related to conversion of 2026 Notes, Shares		16,854,000
Stock-based compensation	333,833		333,833
Other comprehensive income (loss)	5,317			5,317
Net Income (Loss)	(124,775)				(124,775)
Stockholders' (deficit) equity, ending balance at Jul. 31, 2024	$ (728,148)	$ 7	$ 4,118,898	$ 146	$ (4,847,199)
Stockholders' equity, ending balance (in shares) at Jul. 31, 2024		265,181,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net Income (Loss)		$ (124,775)	$ (254,560)	$ (798,946)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities
Depreciation and amortization		73,199	76,388	87,952
Stock-based compensation		333,833	311,745	343,246
Change in fair value of derivative liability		0	0	198,038
Loss on debt extinguishment		0	0	64,910
Amortization of debt discount and issuance cost		41,600	42,636	40,233
Conversion of convertible senior notes attributable to debt discount and issuance costs		107,877	0	0
Operating lease cost, net of accretion		31,462	35,357	36,905
Early exit of lease-related assets		0	(1,040)	597
Gain On Frame Divestiture		0	(10,957)	0
Non-cash interest expense		18,550	19,757	19,270
Other		(13,312)	(11,388)	9,282
Changes in operating assets and liabilities:
Accounts receivable, net		(53,811)	(25,885)	60,998
Deferred commissions		(820)	9,599	(24,170)
Prepaid expenses and other assets		46,623	(59,243)	(36,166)
Accounts payable		14,749	(9,600)	(1,461)
Accrued compensation and benefits		51,923	(6,027)	(19,674)
Accrued expenses and other liabilities		(82,632)	53,191	5,457
Operating leases, net		(30,475)	(40,257)	(46,773)
Deferred revenue		258,940	142,687	127,845
Net cash provided by operating activities		672,931	272,403	67,543
Cash flows from investing activities:
Maturities of investments		774,237	965,040	1,058,116
Purchases of investments		(871,259)	(955,330)	(1,081,246)
Sales of investments		706,363	0	17,999
Proceeds from Frame divestiture		0	5,909	0
Payments for acquisitions, net of cash acquired		(4,500)	0	0
Purchases of property and equipment		(75,252)	(65,404)	(49,058)
Net cash (used in) provided by investing activities		529,589	(49,785)	(54,189)
Cash flows from financing activities:
Repayment of convertible notes		(817,633)	(145,704)	0
Payments of debt extinguishment costs		0	0	(14,709)
Proceeds from unwinding of convertible note hedges		0	0	39,880
Payments for unwinding of warrants		0	0	(18,390)
Proceeds from sales of shares through employee equity incentive plans		51,571	46,501	67,826
Taxes paid related to net share settlement of equity awards		(161,552)	(10,214)	0
Proceeds from the issuance of convertible notes, net of issuance costs		0	0	88,687
Repurchases of common stock		(131,139)	0	(58,570)
Payment of finance lease obligations		(3,876)	(3,292)	(1,089)
Net cash provided by (used in) financing activities		(1,062,629)	(112,709)	103,635
Net increase in cash, cash equivalents and restricted cash		139,891	109,909	116,989
Cash, cash equivalents and restricted cash—beginning of period		515,771	405,862	288,873
Cash, cash equivalents and restricted cash—end of period		655,662	515,771	405,862
Restricted cash	[1]	392	2,842	3,012
Cash and cash equivalents—end of period		655,270	512,929	402,850
Supplemental disclosures of cash flow information:
Cash paid for income taxes		23,647	30,781	20,353
Supplemental disclosures of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable and accrued liabilities		19,275	15,754	17,139
Forfeited paid-in-kind interest recognized in equity upon note conversion		$ 6,019	$ 0	$ 0
[1] Included within other assets—non-current in the consolidated balance sheets.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (124,775)	$ (254,560)	$ (798,946)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jul. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Overview and Summary of Signifi

Overview and Summary of Significant Accounting Policies	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Overview and Summary of Significant Accounting Policies	NOTE 1. OVER VIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Description of Business Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our," or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa. We are a global leader in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Our vision is to make hybrid multicloud deployments simple and free customers to focus on achieving their business outcomes. Our mission is to delight customers with an open hybrid multicloud platform with rich data services to run and manage any application, anywhere. Our Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. Nutanix Cloud Platform supports a wide variety of workloads with varied compute, storage, and network requirements, including business-critical applications, data platforms (including SQL and NoSQL databases and business intelligence applications), general-purpose workloads (including system infrastructure, networking, and security), and end-user computing and virtual desktop infrastructure services, as well as enterprise artificial intelligence ("AI") workloads (including machine learning and generative AI workloads) and cloud native applications (including modern, containerized applications). Our business is organized into a single operating and reportable segment. Our subscription-based business model provides our customers with the flexibility to choose their preferred license levels and durations based on their specific business needs. A subscription-based business model means one in which our products, including associated support and entitlement arrangements, are sold with a defined duration. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners") and delivered directly to our end customers. Principles of Consolidation The accompanying consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the previously outstanding 2.50% convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Risk Credit Risk — Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. We invest only in high-quality credit instruments and maintain our cash and cash equivalents and available-for-sale investments in fixed income securities. Management believes that the financial institutions that hold our investments are financially sound and, accordingly, are subject to minimal credit risk. Our deposits are with multiple institutions, however such deposits may exceed federally insured limits. We provide credit, in the normal course of business, to a number of companies and perform credit evaluations of our customers. Concentration of Revenue and Accounts Receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the fiscal years ended July 31, 2022, 2023 and 2024 , no end customer accounted for more than 10 % of total revenue or accounts receivable. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Fiscal Year Ended July 31, July 31, July 31, Partners 2022 2023 2024 Partner A (1) (1) (1) (1) 16 % Partner B 33 % 32 % 31 % 17 % 12 % Partner C 15 % 16 % 16 % 19 % 10 % Partner D (1) (1) (1) 11 % (1) Partner E 11 % 10 % 11 % (1) (1) (1) Less than 10% Summary of Significant Accounting Policies Cash, Cash Equivalents and Short-Term Investments We classify all highly liquid investments with original maturities of three months or less from the date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation as of each balance sheet date. We classify and account for our marketable securities as available-for-sale securities. We classify our marketable securities with stated maturities greater than twelve months as short-term investments due to our intent and ability to use these securities to support our current operations. Our marketable securities are recorded at their estimated fair value. Unrealized gains or losses on available-for-sale securities are reported in other comprehensive income (loss). We periodically review whether our securities may be other-than-temporarily impaired, including whether or not (i) we have the intent to sell the security or (ii) it is more likely than not that we will be required to sell the security before its anticipated recovery. If one of these factors is met, we will record an impairment loss associated with our impaired investment. The impairment loss will be recorded as a write-down of investments in our consolidated balance sheets and a realized loss within other expense in our consolidated statements of operations. Fair Value Measurement We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all assets and liabilities that are recognized or disclosed at fair value in our consolidated financial statements on a recurring basis. The carrying amounts reported in our consolidated financial statements for cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their fair values due to their short-term nature. The fair value of the previously outstanding 0 % convertible senior notes due 2023 (the "2023 Notes") was determined based on the closing trading price per $ 100 of the 2023 Notes as of the last day of trading for the period. The fair value of the previously outstanding 2.50% convertible senior notes due 2026 was determined based on a binomial model. The fair value of the outstanding 0.25% convertible senior notes due 2027 (the "2027 Notes") is determined based on the closing trading price per $ 100 of the 2027 Notes as of the last day of trading for the period. Convertible Senior Notes Our convertible senior notes, including any embedded conversion features, are accounted for under the traditional convertible debt accounting model and are treated as a liability, net of unamortized issuance costs. The carrying amount of the liability is classified as a current liability if we have committed to settle with current assets; otherwise, it is classified as a long-term liability, as we retain the option to settle conversion requests in shares of our Class A common stock. The embedded conversion features are not remeasured as long as they do not meet the separation requirement of a derivative; otherwise, they are classified as derivative instruments and accounted for as such. Issuance costs are amortized to interest expense using the effective interest rate method over the term of the notes. In accounting for a holder’s exercise in accordance with a note’s original conversion terms of a conversion option for which the carrying amount has previously been reclassified to equity, any unamortized discount remaining at the date of conversion is first recognized as interest, and then the remaining carrying amount of the converted notes is reduced by the cash transferred and then recognized in equity to reflect the shares issued, such that no gain or loss is recognized. In accounting for extinguishments of the notes, the reacquisition price of the extinguished notes is compared to the carrying amount of the respective extinguished notes and a gain or loss is recorded in other expense, net on our consolidated statements of operations. Derivative Liability We evaluate convertible notes or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity. The result of this accounting guidance could result in the fair value of a financial instrument being classified as a derivative instrument and recorded at fair market value at each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded on our consolidated statements of operations as other income or other expense. Once the criteria for conversion is fixed, the derivative instrument is marked to fair value and reclassified to equity. Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations of our customers and maintain an allowance for credit losses. The allowance for credit losses is based on the best estimate of the amount of probable credit losses in existing accounts receivable. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations (e.g., bankruptcy filings or substantial downgrading of credit ratings), we record an allowance for credit losses in order to reduce the net recognized receivable to the amount we reasonably believe will be collected. For all other customers, we record an allowance for credit losses based on the length of time the receivable is past due and our historical experience of collections and write-offs. The changes in the allowance for credit losses are as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Allowance for credit losses—beginning balance $ 892 $ 644 $ 733 Charged to allowance for credit losses 200 212 830 Recoveries ( 80 ) ( 123 ) — Write-offs ( 368 ) — ( 791 ) Allowance for credit losses—ending balance $ 644 $ 733 $ 772 Property and Equipment Property and equipment, including leasehold improvements, are stated at cost, less accumulated depreciation and amortization. We include the cost to acquire demonstration units and the related accumulated depreciation in property and equipment as such units are generally not available for sale. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the related assets. Leases We determine if an arrangement is or contains a lease at inception by evaluating various factors, including whether a vendor’s right to substitute an identified asset is substantive. Lease classification is determined at the lease commencement date when the leased assets are made available for our use. Operating leases are included in operating lease right-of-use assets, operating lease liabilities—current and operating lease liabilities—non-current in our consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other current liabilities and other liabilities—non-current in our consolidated balance sheets. Right-of-use assets ("ROU assets") represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist primarily of fixed payments under the arrangement, less any lease incentives, such as rent holidays. Variable lease payments not dependent on an index or a rate are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance, property taxes and utilities. We use an estimate of our incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. In determining the appropriate IBR, we consider information including, but not limited to, our credit rating, the lease term and the currency in which the arrangement is denominated. For leases which commenced prior to our adoption of Accounting Standards Update ("ASU") 2016-02, Leases ("ASC 842"), we used the IBR as of August 1, 2019. Our lease terms may include renewal options, which are not included in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Lease costs are recognized on a straight-line basis as operating expenses within our consolidated statements of operations. We present lease payments within cash flows from operations within our consolidated statements of cash flows. For our operating leases, we account for lease and non-lease components as a single lease component. Additionally, we do not record leases on our consolidated balance sheet that have a lease term of 12 months or less at the lease commencement date. Goodwill, Intangible Assets and Other Long-Lived Assets Goodwill represents the future economic benefits arising from other assets acquired in a business combination or an acquisition that are not individually identified and separately recorded. The excess of the purchase price over the estimated fair value of net assets of businesses acquired in a business combination is recognized as goodwill. Intangible assets consist of identifiable intangible assets, including developed technology, customer relationships and trade names, resulting from business combinations. Finite-lived intangible assets are recorded at fair value, net of accumulated amortization. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense is included as a component of cost of product revenue and sales and marketing expense in our consolidated statements of operations. Amounts included in sales and marketing expense relate to customer relationships and trade names. Goodwill and other intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead tested for impairment at least annually, as of May 1 of each year. Such goodwill and other intangible assets may also be tested for impairment between annual tests in the presence of impairment indicators such as, but not limited to: (i) a significant adverse change in legal factors or in the business climate; (ii) a substantial decline in our market capitalization; (iii) an adverse action or assessment by a regulator; (iv) unanticipated competition; (v) loss of key personnel; (vi) a more likely-than-not expectation of the sale or disposal of a reporting unit or a significant portion thereof; (vii) a realignment of our resources or restructuring of our existing businesses in response to changes to industry and market conditions; (viii) testing for recoverability of a significant asset group within a reporting unit; or (ix) a higher discount rate used in the impairment analysis as impacted by an increase in interest rates. Goodwill is tested for impairment by comparing the reporting unit's carrying value, including goodwill, to the fair value of the reporting unit. We operate under one reporting unit and for our annual goodwill impairment test, we determine the fair value of our reporting unit based on our enterprise value. We may elect to utilize a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If, after assessing the qualitative factors, we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying value, an impairment analysis will be performed. We compare the fair value of our reporting unit with its carrying amount and if the carrying value of the reporting unit exceeds its fair value, an impairment loss will be recognized. Long-lived assets, such as property and equipment and finite-lived intangible assets subject to depreciation and amortization, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Among the factors and circumstances we consider in determining recoverability are: (i) a significant decrease in the market price of a long-lived asset; (ii) a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; (iii) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, including an adverse action or assessment by a regulator; (iv) an accumulation of costs significantly in excess of the amount originally expected for the acquisition; and (v) current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. There have been no indicators of impairment of goodwill, intangible assets or other long-lived assets and we did not record any material impairment losses during fiscal 2022, 2023 or 2024 . Revenue Recognition The core principle of ASC 606 is to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. This principle is achieved by applying the following five-step approach: • Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. • Identification of the performance obligations in the contract — Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we apply judgment to determine whether promised goods or services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. • Determination of the transaction price — The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer. • Allocation of the transaction price to the performance obligations in the contract — If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP, taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. • Recognition of revenue when, or as, performance obligations are satisfied — We satisfy performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied with the transfer of a promised good or service to a customer. For additional details on revenue recognition, refer to Note 2 of Notes to Consolidated Financial Statements. Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative SSP basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations. Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. The balance of unbilled accounts receivable, included in accounts receivable, net on our consolidated balance sheets, was $ 16.3 million and $ 41.1 million as of July 31, 2023 and 2024, respectively. Our customers are typically invoiced upfront, including invoices for multi-year subscriptions, with payment terms of 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectability of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2023 and 2024 is presented in the accompanying consolidated balance sheets. Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in our consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in our consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle, and other factors. Deferred costs are periodically reviewed for impairment. Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our consolidated statements of operations. Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertains to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet date. Cost of Revenue Cost of revenue consists of cost of product revenue and cost of support, entitlements and other services revenue. Personnel costs associated with our operations and global customer support organizations consist of salaries, benefits and stock-based compensation. Allocated costs consist of certain facilities, depreciation and amortization, recruiting, and information technology costs, allocated based on headcount. Warranties We generally provide a one-year warranty on hardware sold by us and a 90-day warranty on software licenses. The hardware warranty provides for parts replacement for defective components and the software warranty provides for bug fixes. With respect to the hardware warranty obligation, we have a warranty agreement with our contract manufacturers under which the OEMs are generally required to replace defective hardware within three years of shipment. Furthermore, our post-contract customer support ("PCS") agreements provide for the same parts replacement that customers are entitled to under the warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to the customers’ critical business applications. Substantially all customers purchase PCS agreements. Given the warranty agreement with our OEMs and considering that substantially all products are sold together with PCS agreements, we generally have very limited exposure related to warranty costs and therefore no warranty reserve has been recognized. Research and Development Our research and development expense consists primarily of product development personnel costs, including salaries and benefits, stock-based compensation and allocated facilities, IT, and recruiting costs. Research and development costs are expensed as incurred. Currently, we expense the software development costs incurred in the research and development of new products and enhancements to existing products as incurred, as from the inception of the product development, our software products are primarily intended to be marketed and sold to customers on-premises, either standalone and/or with other product offerings. Stock-Based Compensation Stock-based compensation expense is measured based on the grant date fair value of share-based awards. The fair value of the purchase rights under our 2016 Employee Stock Purchase Plan ("2016 ESPP") is estimated using the Black-Scholes-Merton ("Black-Scholes") option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates, and expected dividend yield. The fair value of restricted stock units ("RSUs") is determined using the fair value of our common stock on the date of grant. The fair value of awards with a market-based condition is measured using a Monte Carlo simulation, which requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We grant stock awards with service conditions only and with both service and performance or market-based conditions. We recognize stock-based compensation expense for employee stock awards with a service condition only using the straight-line method over the requisite service period of the awards, which is generally the vesting period. We use the graded vesting attribution method to recognize stock-based compensation expense related to employee stock awards that contain both service and performance or market-based conditions. The fair value of the 2016 ESPP purchase rights is recognized as expense on a straight-line basis over the offering period. We account for forfeitures of all share-based awards when they occur. Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured at the average exchange rate in effect during the reporting period. At the end of each reporting period all monetary assets and liabilities of our subsidiaries are remeasured at the current U.S. dollar exchange rate at the end of the reporting period. Remeasurement gains and losses are included within other expense, net in our consolidated statements of operations. During the fiscal years ended July 31, 2022, 2023 and 2024 , we recognized foreign currency losses of $ 3.2 million, $ 1.6 million and $ 4.3 million, respectively. To date, we h

Revenue, Deferred Revenue and D

Revenue, Deferred Revenue and Deferred Commissions	12 Months Ended
	Jul. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Revenue, Deferred Revenue and Deferred Commissions	NOTE 2. REVENUE, DEFERRED REVENUE AND DEFERRED COMMISSIONS Disaggregation of Revenue and Revenue Recognition Nutanix Cloud Platform can be deployed in core data centers, at the edge, or in public clouds, running on a variety of qualified hardware platforms (including out Nutanix-branded NX hardware line), in popular public cloud environments such as Amazon Web Services ("AWS") and Microsoft Azure through Nutanix Cloud Clusters, or, in the case of our cloud-based software and software-as-a-service ("SaaS") offerings, via hosted service. Our subscription term-based licenses are sold separately, or can also be sold alongside configured-to-order servers. Our subscription term-based licenses typically have durations ranging from one to five years . Our cloud-based SaaS subscriptions generally have durations extending up to five years. The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Subscription $ 1,433,773 $ 1,730,848 $ 2,016,776 Professional services 91,744 91,841 100,852 Other non-subscription product (1) 55,279 40,206 31,188 Total revenue $ 1,580,796 $ 1,862,895 $ 2,148,816 (1) Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation. Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based software-as-a-service offerings. • Ratable — We recognize revenue from software entitlement and support subscriptions and SaaS offerings ratably over the contractual service period, the substantial majority of which relate to software entitlement and support subscriptions. These offerings represented approximately $ 770.4 million, $ 905.8 million and $ 1.0 billion of our subscription revenue for fiscal 2022, 2023 and 2024, respectively. • Upfront — Revenue from our subscription software licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. These subscription software licenses represented approximately $ 663.4 million, $ 825.0 million and $ 987.8 million of our subscription revenue for fiscal 2022, 2023 and 2024, respectively. Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed. Other non-subscription product revenue — Other non-subscription product revenue includes approximately $ 49.7 million, $ 37.4 million and $ 27.9 million of non-portable software revenue for fiscal 2022, 2023 and 2024 , respectively, and approximately $ 5.6 million, $ 2.8 million and $ 3.3 million of hardware revenue for fiscal 2022, 2023 and 2024, respectively. • Non-portable software revenue — Non-portable software revenue includes sales of our platform when delivered on a configured-to-order server by us or one of our OEM partners. The software licenses associated with these sales are typically non-portable and can be used over the life of the server on which the software is delivered. Revenue from our non-portable software products is generally recognized upon transfer of control to the customer. • Hardware revenue — In the infrequent transactions where the hardware platform is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis. We consider the amount allocated to hardware revenue to be equivalent to the cost of the hardware procured. Hardware revenue is generally recognized upon transfer of control to the customer. Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2022 $ 1,445,538 $ 367,590 Additions (1) 2,012,389 187,381 Revenue/commissions recognized ( 1,862,895 ) ( 196,980 ) Balance as of July 31, 2023 1,595,032 357,991 Additions (1) 2,426,490 218,876 Revenue/commissions recognized ( 2,148,816 ) ( 218,056 ) Balance as of July 31, 2024 $ 1,872,706 $ 358,811 (1) Includes both billed and unbilled amounts. During the fiscal year ended July 31, 2023 , we recognized revenue of approximately $ 696.0 million pertaining to amounts deferred as of July 31, 2022. During the fiscal year ended July 31, 2024 , we recognized revenue of approximately $ 771.2 million pertaining to amounts deferred as of July 31, 2023. Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $ 2.1 billion as of July 31, 2024 , of which we expect to recognize approximately 52 % over the next 12 months, and the remainder thereafter.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 3. FAIR VALUE MEASUREMENTS The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy based on the observability of the inputs available in the market used to measure fair value as follows: • Level I — Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; • Level II — Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and • Level III — Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. Assets Measured at Fair Value on a Recurring Basis Cash equivalents and short-term investments Our money market funds are classified within Level I due to the highly liquid nature of these assets and have unadjusted inputs, quoted prices in active markets for these assets at the measurement date from the financial institution that carries these investment securities. Our investments in available-for-sale debt securities such as commercial paper, corporate bonds and U.S. government securities are classified within Level II. The fair value of these securities is priced by using inputs based on non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models such as discounted cash flow techniques. Convertible note receivable In May 2023, we sold our Frame Desktop-as-a-Service business. As part of the consideration for the sale, we received a $ 5.0 million interest-bearing convertible note. We have elected the fair value option for the convertible note and will record the changes in its fair value at each reporting period. As of July 31, 2024 , the fair value of the convertible note was determined to be approximately $ 5.2 million. We consider this convertible note to be classified within Level III. The fair value is determined by considering the convertible note’s principal and accrued interest, as well as the convertible note’s option to convert into equity securities, using inputs including debt yields, volatility data, and the value of the underlying equity into which the convertible note could be converted. The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 211,319 $ — $ — $ 211,319 U.S. Government securities — 6,999 — 6,999 Commercial paper — 34,830 — 34,830 Short-term investments: Corporate bonds — 452,703 — 452,703 Commercial paper — 215,219 — 215,219 U.S. Government securities — 256,544 — 256,544 Total measured at fair value $ 211,319 $ 966,295 $ — $ 1,177,614 Cash 259,781 Total cash, cash equivalents and short-term investments $ 1,437,395 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,700 $ 5,700 As of July 31, 2024 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 352,295 $ — $ — $ 352,295 U.S. Government securities — 99 — 99 Commercial paper — 1,747 — 1,747 Short-term investments: Corporate bonds — 233,065 — 233,065 Commercial paper — 33,770 — 33,770 U.S. Government securities — 72,237 — 72,237 Total measured at fair value $ 352,295 $ 340,918 $ — $ 693,213 Cash 301,129 Total cash, cash equivalents and short-term investments $ 994,342 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,150 $ 5,150 Financial Instruments Not Recorded at Fair Value on a Recurring Basis We report our financial instruments at fair value, with the exception of the previously outstanding 2026 Notes and the 2027 Notes. Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2023 As of July 31, 2024 Carrying Estimated Carrying Estimated (in thousands) 2026 Notes $ 649,630 $ 1,043,889 $ — $ — 2027 Notes 568,535 497,410 570,073 631,178 Total $ 1,218,165 $ 1,541,299 $ 570,073 $ 631,178 The carrying value of the 2026 Notes as of July 31, 2023 included $ 47.6 million of non-cash interest expense that was added to the principal balance, net of unamortized debt discounts of $ 132.8 million and unamortized debt issuance costs of $ 15.2 million. The carrying value of the 2027 Notes as of July 31, 2023 and 2024 was net of unamortized debt issuance costs of $ 6.5 million and $ 4.9 million, respectively. The total estimated fair value of the 2026 Notes was based on a binomial model. We considered the fair value of the 2026 Notes to be a Level III valuation, as the 2026 Notes were not publicly traded. The Level III inputs used to determine the estimated fair value of the 2026 Notes included the conversion rate, risk-free interest rate, discount rate, volatility, and the price of our Class A common stock. The total estimated fair value of the 2027 Notes was determined based on the closing trading price per $ 100 of the 2027 Notes as of the last day of trading for the period. We consider the fair value of the 2027 Notes to be a Level II valuation due to the limited trading activity.

Balance Sheet Components

Balance Sheet Components	12 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	NOTE 4. BALANCE SHEET COMPONENTS Short-Term Investments The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2023 and 2024, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, as of July 31, 2023 and 2024, we did not record any credit losses for these investments. The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 209,076 Due in one to three years 129,996 Total $ 339,072 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consists of the following: As of July 31, 2023 2024 (in thousands) Prepaid operating expenses $ 84,998 $ 62,815 VAT receivables 5,954 8,017 Other current assets 56,135 26,475 Total prepaid expenses and other current assets $ 147,087 $ 97,307 The decrease in prepaid expenses and other current assets from July 31, 2023 to July 31, 2024 was due primarily to the release of the insurance receivable and the settlement payment related to the February 2023 settlement of two securities class actions, as the settlement was paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 7. Property and Equipment, Net Property and equipment, net consists of the following: Estimated As of July 31, Useful Life 2023 2024 (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 381,140 $ 421,559 Demonstration units 12 60,985 59,570 Leasehold improvements (1) 64,667 64,607 Software (2) 9,238 29,014 Furniture and fixtures 60 16,132 16,169 Total property and equipment, gross 532,162 590,919 Less: accumulated depreciation ( 420,297 ) ( 454,739 ) Total property and equipment, net $ 111,865 $ 136,180 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. (2) The estimated useful life of software ranges from 36 to 120 months, representing the period during which the software is expected to contribute, either directly or indirectly, to our future cash flows. Depreciation expense related to our property and equipment was $ 69.3 million, $ 63.3 million and $ 65.6 million for the fiscal years ended July 31, 2022, 2023 and 2024, respectively. Intangible Assets, Net Intangible assets, net consists of the following: As of July 31, 2023 2024 (in thousands) Developed technology $ 78,267 $ 79,838 Customer relationships 8,860 11,230 Trade name 4,170 4,200 Total intangible assets, gross 91,297 95,268 Less: Accumulated amortization of developed technology ( 73,411 ) ( 76,804 ) Accumulated amortization of customer relationships ( 8,823 ) ( 9,111 ) Accumulated amortization of trade name ( 4,170 ) ( 4,200 ) Total accumulated amortization ( 86,404 ) ( 90,115 ) Total intangible assets, net $ 4,893 $ 5,153 Amortization expense related to our intangible assets is recognized in our consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name. The changes in the net book value of intangible assets, net are as follows: As of July 31, 2023 2024 (in thousands) Intangible assets, net—beginning balance $ 15,829 $ 4,893 Amortization of intangible assets (1) ( 10,697 ) ( 3,709 ) Acquisition of intangible assets — 3,969 Divestiture of Frame intangible assets ( 239 ) — Intangible assets, net—ending balance $ 4,893 $ 5,153 (1) Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense . The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2025 $ 2,540 2026 777 2027 777 2028 353 2029 353 Thereafter 353 Total $ 5,153 Goodwill The changes in the carrying amount of goodwill are as follows: Carrying Amount (in thousands) Balance at July 31, 2022 $ 185,260 Adjustment for Frame divestiture ( 322 ) Balance at July 31, 2023 184,938 Adjustment for acquisition 297 Balance at July 31, 2024 $ 185,235 Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, 2023 2024 (in thousands) Accrued commissions and taxes $ 36,882 $ 40,714 Payroll taxes payable 17,427 31,797 Accrued vacation 24,840 26,772 Contributions to ESPP withheld 10,145 24,676 Accrued bonus 16,404 17,863 Accrued benefits 12,391 16,580 Accrued wages and taxes 11,485 16,255 Retirement 401(k) payable 1,915 701 Other 12,190 20,244 Total accrued compensation and benefits $ 143,679 $ 195,602 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consists of the following: As of July 31, 2023 2024 (in thousands) Income taxes payable $ 2,185 $ 1,927 Accrued professional services 1,978 2,004 Litigation settlement reserves 71,000 — Software usage liability 11,248 — Other 22,858 21,036 Total accrued expenses and other current liabilities $ 109,269 $ 24,967 The decrease in accrued expenses and other current liabilities from July 31, 2023 to July 31, 2024 was due primarily to the release of the litigation settlement reserve related to the settlement of two securities class actions, which was agreed to in February 2023 but paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 7. In addition, we released the software usage liability related to the completed Audit Committee investigation, as we settled with the vendor.

Convertible Senior Notes

Convertible Senior Notes	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	NOTE 5. CONVERTIBLE SENIOR NOTES 2023 Notes In January 2018, we issued the 2023 Notes with a 0 % interest rate for an aggregate principal amount of $ 575.0 million, due in 2023, in a private placement to qualified institutional buyers pursuant to Rule144A under the Securities Act. On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $ 416.5 million in aggregate principal amount of 2023 Notes for $ 477.3 million in aggregate principal amount of 2027 Notes. We also entered into privately negotiated transactions with certain holders of the 2023 Notes pursuant to which we repurchased approximately $ 12.8 million in aggregate principal amount of 2023 Notes for cash. Following the closing of these exchanges and repurchases, approximately $ 145.7 million in aggregate principal amount of 2023 Notes remained outstanding with terms unchanged. In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $ 145.7 million. The following table sets forth the total interest expense recognized related to the 2023 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Interest expense related to amortization of debt issuance 844 248 — Note Hedges and Warrants Concurrently with the offering of the 2023 Notes in January 2018, we entered into convertible note hedge transactions with certain bank counterparties, whereby we have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a conversion price of approximately $ 48.85 per share, subject to adjustment for certain specified events. The total cost of the convertible note hedge transactions was approximately $ 143.2 million. In addition, we sold warrants to certain bank counterparties, whereby the holders of the warrants have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a price of $ 73.46 per share, subject to adjustment for certain specified events. We received approximately $ 88.0 million in cash proceeds from the sale of these warrants. In September 2021, in connection with the exchange and repurchase transactions described above, we terminated portions of the convertible note hedge transactions and warrant transactions previously entered into with certain financial institutions in connection with the issuance of the 2023 Notes. The net effect of these unwind transactions was a $ 21.5 million cash payment received, consisting of an $ 18.4 million payment for the warrant unwind and the receipt of $ 39.9 million from the hedge unwind. The amounts paid and received as part of the unwind transactions were recorded to additional paid-in capital within the consolidated balance sheet. In January 2023, the convertible note hedges and warrant transactions expired concurrently with the maturity of the 2023 Notes. No settlement is required as the stock has remained below the strike price throughout the unwind settlement averaging period. 2026 Notes In September 2020, we issued $ 750.0 million in aggregate principal amount of the 2026 Notes to BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital, LP ("Bain"). The total net proceeds from this offering were approximately $ 723.7 million, after deducting $ 26.3 million of debt issuance costs. The 2026 Notes bore interest at a rate of 2.50 % per annum, with such interest paid in kind ("PIK") on the 2026 Notes held by Bain through an increase in the principal amount of the 2026 Notes, and to be paid in cash on any 2026 Notes transferred to entities that are not affiliated with Bain. Interest on the 2026 Notes accrued from the date of issuance, September 24, 2020, and was added to the principal amount on a semi-annual basis (on March 15 and September 15 of each year). The 2026 Notes were set to mature on September 15, 2026, subject to earlier conversion, redemption or repurchase. In accordance with accounting guidance on embedded conversion features, at issuance, we valued and bifurcated the conversion option associated with the 2026 Notes from the respective host debt instrument, which is treated as a debt discount, and initially recorded the conversion option of $ 230.9 million as a derivative liability in our consolidated balance sheet, with the corresponding amount recorded as a discount to the 2026 Notes and amortized over the term of the 2026 Notes using the effective interest method. Upon the conversion price of the 2026 Notes becoming fixed, subject to customary anti-dilution and other adjustments, in September 2021, the embedded conversion option for the 2026 Notes no longer required bifurcation because the conversion features were considered indexed to our own equity and met the equity classification conditions. The carrying amount of the derivative liability of $ 698.2 million as of that date was reclassified to additional paid-in capital within our consolidated balance sheet. The remaining debt discount that arose from the original bifurcation was amortized over the term of the 2026 Notes. On June 6, 2024, Bain delivered a notice of conversion to convert $ 817.6 million aggregate principal amount of the 2026 Notes, representing all of the outstanding principal amount as of that date. Under the terms of the indenture governing the 2026 Notes, the conversion was settled by paying the $ 817.6 million principal amount in cash and delivering the conversion spread of approximately 16.9 million shares of our Class A common stock. The cash portion was settled using a portion of our existing cash, cash equivalents and short-term investments. The 2026 Notes were converted in accordance with its original terms and conditions. Upon conversion, because the carrying amount of the conversion option was previously reclassified to equity, the unamortized discount remaining at the date of conversion was recognized as interest expense. The remaining carrying amount of the 2026 Notes was reduced by the cash transferred and then recognized in equity, such that no gain or loss was recognized. In addition, the accrued and unpaid interest as of the conversion date was forgiven pursuant to the terms of the indenture and recognized in equity. The 2026 Notes consisted of the following: As of July 31, 2023 2024 (in thousands) Principal amounts: Principal $ 750,000 $ — Non-cash interest expense converted to principal 47,569 — Unamortized debt discount (conversion feature) (1) ( 132,769 ) — Unamortized debt issuance costs (1) ( 15,170 ) — Net carrying amount $ 649,630 $ — (1) Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate was 7.05 % . The following table sets forth the total interest expense recognized related to the 2026 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Interest expense related to amortization of debt discount $ 34,180 $ 36,668 $ 35,955 Interest expense related to amortization of debt issuance 3,906 4,189 4,107 Non-cash interest expense 19,270 19,757 18,550 Interest expense related to conversion of 2026 Notes — — 107,877 Total interest expense $ 57,356 $ 60,614 $ 166,489 Non-cash interest expense was related to the 2.5% PIK interest that we accrued from the issuance of the 2026 Notes through the conversion date and was recognized within other expense, net in our consolidated statement of operations and other liabilities–non-current in our consolidated balance sheet. The accrued PIK interest was converted to the principal balance of the 2026 Notes at each payment date. 2027 Notes In September 2021, we issued $ 575 million in aggregate principal amount of 0.25 % convertible senior notes due 2027 consisting of (i) approximately $ 477.3 million principal amount of 2027 Notes in exchange for approximately $ 416.5 million principal amount of the 2023 Notes (the "Exchange Transactions") and (ii) approximately $ 97.7 million principal amount of 2027 Notes for cash (the "Subscription Transactions"). We did not receive any cash proceeds from the Exchange Transactions. The net cash proceeds from the Subscription Transactions were approximately $ 88.4 million after deducting the offering expenses for both the Exchange Transactions and the Subscription Transactions. We used (i) approximately $ 14.7 million of the net cash proceeds from the Subscription Transactions to repurchase approximately $ 12.8 million principal amount of the 2023 Notes and (ii) approximately $ 58.5 million of the net cash proceeds from the Subscription Transactions to repurchase approximately 1.4 million shares of our Class A common stock. The 2027 Notes bear interest at a rate of 0.25% per annum and pay interest semi-annually in arrears on each April 1 and October 1. The 2027 Notes will mature on October 1, 2027, unless earlier converted, redeemed or repurchased. The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $ 1,000 of principal of the 2027 Notes is initially convertible into 17.3192 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $ 57.74 per share, subject to customary anti-dilution adjustments. Holders of these 2027 Notes may convert their 2027 Notes at their option at any time prior to the close of the business day immediately preceding July 1, 2027, only under the following circumstances: (1) during any fiscal quarter, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding fiscal quarter is greater than or equal to 130 % of the then applicable conversion price for the Notes per share of common stock; (2) during the five business day period after any consecutive five trading day period in which, for each trading day of that period, the trading price per $ 1,000 principal amount of 2027 Notes for such trading day was less than 98 % of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day; (3) if we call the 2027 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of certain specified corporate events. Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. Holders who convert their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2027 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2027 Notes) prior to the maturity date, holders of the 2027 Notes may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to 100 % of the principal amount of the repurchased 2027 Notes, plus accrued and unpaid interest thereon. In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $ 64.9 million difference between the total reacquisition price paid and the net carrying amount of the 2023 Notes was recognized as a debt extinguishment loss within other expense, net in our consolidated statement of operations. The 2027 Notes consisted of the following: As of July 31, 2023 2024 (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 6,465 ) ( 4,927 ) Net carrying amount $ 568,535 $ 570,073 (1) Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %. As of July 31, 2024, the remaining life of the 2027 Notes was approximately 3.2 years . The following table sets forth the total interest expense recognized related to the 2027 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Contractual interest expense $ 1,229 $ 1,720 $ 1,352 Interest expense related to amortization of debt issuance 1,302 1,530 1,538 Total interest expense $ 2,531 $ 3,250 $ 2,890

Leases

Leases	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Leases	NOTE 6. LEASES We have operating leases for offices, research and development facilities and data centers and finance leases for certain data center equipment. Our leases have remaining lease terms of one year to approximately six years , some of which include options to renew or terminate. We do not include renewal options in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Our lease agreements do not contain any residual value guarantees or restrictive covenants. Total operating lease cost was $ 43.3 million, $ 42.4 million and $ 38.6 million for the fiscal years ended July 31, 2022, 2023 and 2024 , respectively, excluding short-term lease costs, variable lease costs and sublease income, each of which were not material. Variable lease costs primarily include common area maintenance charges. Total finance lease cost was $ 2.4 million, $ 3.9 million, and $ 4.8 million for the fiscal years ended July 31, 2022, 2023 and 2024, respectively. During fiscal 2022, we signed agreements to early exit certain office spaces in the United States. The reduction in the lease term resulted in a decrease to the carrying amount of the operating lease liability and the operating lease right-of-use asset on our consolidated balance sheet as of July 31, 2022. In addition, we recorded $ 0.6 million of expense in our consolidated statement of operations for the fiscal year ended July 31, 2022. During fiscal 2023, we signed agreements to early exit certain office spaces in the United States and the Netherlands. The reductions in the lease terms resulted in decreases to the carrying amounts of the operating lease liabilities and the operating lease right-of-use assets on our consolidated balance sheet as of July 31, 2023. In addition, we recorded $ 1.7 million of expense in our consolidated statement of operations for the fiscal year ended July 31, 2023. Supplemental balance sheet information related to our leases is as follows: As of July 31, 2023 2024 (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 181,226 $ 180,843 Accumulated amortization ( 87,672 ) ( 71,710 ) Operating lease right-of-use assets, net $ 93,554 $ 109,133 Operating lease liabilities—current $ 29,567 $ 24,163 Operating lease liabilities—non-current 68,940 90,359 Total operating lease liabilities $ 98,507 $ 114,522 Weighted average remaining lease term (in years): 5.0 4.8 Weighted average discount rate: 6.1 % 6.4 % As of July 31, 2023 2024 (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 18,279 $ 19,345 Accumulated amortization (1) ( 5,558 ) ( 9,412 ) Finance lease right-of-use assets , net (1) $ 12,721 $ 9,933 Finance lease liabilities—current (2) $ 3,518 $ 3,954 Finance lease liabilities—non-current (3) 9,722 6,666 Total finance lease liabilities $ 13,240 $ 10,620 Weighted average remaining lease term (in years): 3.7 2.9 Weighted average discount rate: 6.8 % 7.0 % (1) Included in our consolidated balance sheets within property and equipment, net. (2) Included in our consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in our consolidated balance sheets within other liabilities—non-current. Supplemental cash flow and other information related to our leases is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 48,509 $ 46,886 $ 37,973 Operating cash flows from finance leases $ — $ — $ 885 Financing cash flows from finance leases $ 1,089 $ 4,757 $ 3,601 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ 55,797 $ 10,358 $ 46,153 Finance leases $ 4,529 $ 7,827 $ 1,066 The undiscounted cash flows for our lease liabilities as of July 31, 2024 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2025 $ 30,125 $ 4,576 $ 34,701 2026 26,064 3,874 29,938 2027 23,780 2,164 25,944 2028 22,968 1,152 24,120 2029 17,252 41 17,293 Thereafter 13,985 — 13,985 Total lease payments 134,174 11,807 145,981 Less: imputed interest ( 19,652 ) ( 1,187 ) ( 20,839 ) Total lease obligation 114,522 10,620 125,142 Less: current lease obligations ( 24,163 ) ( 3,954 ) ( 28,117 ) Long-term lease obligations $ 90,359 $ 6,666 $ 97,025 As of July 31, 2024 , we had additional operating lease commitments of approximately $ 2.3 million on an undiscounted basis for certain office leases that have not yet commenced. These operating leases will commence during fiscal 2025, with lease terms of approximately one year .

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 7. COMMITMENTS AND CONTINGENCIES Purchase Commitments In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of July 31, 2024, we had approximately $ 110.6 million of non-cancelable purchase obligations and other commitments pertaining to our daily business operations, and approximately $ 85.2 million in the form of guarantees to certain of our contract manufacturers. Guarantees and Indemnifications We have entered into agreements with some of our Partners and customers that contain indemnification provisions in the event of claims alleging that our products infringe the intellectual property rights of a third party. The scope of such indemnification varies, and may include, in certain cases, the ability to cure the indemnification by modifying or replacing the product at our own expense, requiring the return and refund of the infringing product, procuring the right for the partner and/or customer to continue to use or distribute the product, as applicable, and/or defending the partner or customer against and paying any damages from third-party actions based upon claims of infringement. Other guarantees or indemnification arrangements include guarantees of product and service performance. We have also agreed to indemnify our directors, executive officers and certain other officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by us, arising out of that person’s services as a director or officer of our company or that person’s services provided to any other company or enterprise at our request. We maintain director and officer insurance coverage that may enable us to recover a portion of any future amounts paid. The fair value of liabilities related to indemnifications and guarantee provisions are not material and have not had any material impact on our consolidated financial statements to date. Legal Proceedings In February 2023, we settled the two previously disclosed securities class actions that were brought on behalf of persons or entities who purchased or otherwise acquired our securities and/or transacted in publicly traded call options and/or put options on our stock between November 30, 2017 and May 30, 2019. The total settlement amount was $ 71.0 million, which was accrued as of July 31, 2023 and included within accrued expenses and other current liabilities on our consolidated balance sheet. In June 2023, $ 31.1 million of the settlement funds were deposited in escrow and were included within prepaid expenses and other current assets on our consolidated balance sheet as of July 31, 2023. In October 2023, the court granted final approval of the settlement and the funds were subsequently released from escrow and paid out to the plaintiffs. The settlement accrual was partially offset by a receivable of $ 39.9 million for amounts recoverable under our applicable insurance policies, which was included within prepaid expenses and other current assets on our consolidated balance sheet as of July 31, 2023. During the fiscal year ended July 31, 2023, we recorded charges of $ 38.7 million for the settlement and applicable legal fees, net of our insurance receivable. In September 2023, we settled the previously disclosed securities class action that was brought on behalf of a putative class consisting of persons or entities who purchased or otherwise acquired our securities between September 21, 2021 and March 6, 2023. The settlement payment was not material. In November 2023, the court dismissed the securities class action pursuant to the settlement agreement with prejudice as to the lead plaintiff and without prejudice as to the other members of the putative class. In addition, in December 2023, the plaintiff in the related previously disclosed stockholder derivative action voluntarily dismissed the action. We are not currently a party to any legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Stockholders' Equity	NOTE 8. STOCKHOLDERS’ EQUITY Effective January 3, 2022, all of our then outstanding shares of Class B common stock, par value $ 0.000025 per share, were automatically converted into the same number of shares of our Class A common stock, par value $ 0.000025 per share, pursuant to the terms of our Amended and Restated Certificate of Incorporation. No additional shares of Class B common stock will be issued following such conversion. As a result, as of July 31, 2024 , we had one class of outstanding common stock consisting of Class A common stock. In December 2022, our stockholders approved an amendment and restatement of our Amended and Restated Certificate of Incorporation, which includes the removal of all provisions related to Class B common stock. As of July 31, 2024 , we had 1.0 billion shares of Class A common stock authorized, with a par value of $ 0.000025 per share. As of July 31, 2024 , we had 265.2 million shares of Class A common stock issued and outstanding. Holders of Class A common stock are entitled to one vote for each share of Class A common stock held on all matters submitted to a vote of stockholders. Share Repurchases In September 2021, we used approximately $ 58.5 million of the net cash proceeds from the issuance of $ 97.7 million in aggregate principal amount of 2027 Notes to repurchase 1.4 million shares of Class A common stock in open market transactions at an average price of $ 42.77 per share. For additional details on these transactions, refer to Note 5. In August 2023, our Board of Directors authorized the repurchase of up to $ 350.0 million of our Class A common stock. Repurchases may be made from time to time through open market purchases or through privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The authorization has no expiration date, does not obligate us to acquire any particular amount of our common stock, and may be suspended at any time at our discretion. During the fiscal year ended July 31, 2024 , we repurchased 2.6 million shares of Class A common stock in open market transactions at a weighted average price of $ 50.77 per share for an aggregate purchase price of $ 131.1 million. As of July 31, 2024 , $ 218.9 million remained available for future share repurchases under the authorization. Common Stock Reserved for Issuance As of July 31, 2024, we had reserved shares of common stock for future issuance as follows: As of July 31, 2024 (in thousands) Shares reserved for future equity grants 19,964 Shares underlying outstanding stock options 258 Shares underlying outstanding restricted stock units 22,175 Shares reserved for future employee stock purchase plan awards 10,747 Total 53,144

Equity Incentive Plans

Equity Incentive Plans	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	NOTE 9. EQUITY INCENTIVE PLANS Stock Plans We have one active equity incentive plan, the 2016 Equity Incentive Plan (the "2016 Plan"), and two inactive equity incentive plans, the 2010 Stock Plan ("2010 Plan") and the 2011 Stock Plan ("2011 Plan") (collectively, the "Stock Plans"). Our stockholders approved the 2016 Plan in March 2016 and it became effective in connection with our initial public offering ("IPO"). As a result, at the time of the IPO, we ceased granting additional stock awards under the 2010 Plan and 2011 Plan and both plans were terminated. Any outstanding stock awards under the 2010 Plan and 2011 Plan remain outstanding, subject to the terms of the applicable plan and award agreements, until such shares are issued under those stock awards, by exercise of stock options or settlement of RSUs, or until those stock awards become vested or expired by their terms. Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, RSUs, and stock appreciation rights to employees, directors and consultants. We initially reserved 22.4 million shares of our Class A common stock for issuance under the 2016 Plan. The number of shares of Class A common stock available for issuance under the 2016 Plan also includes an annual increase on the first day of each fiscal year, beginning in fiscal 2018, equal to the lesser of: 18.0 million shares, 5 % of the outstanding shares of all classes of common stock as of the last day of our immediately preceding fiscal year, or such other amount as may be determined by our Board of Directors. Accordingly, on August 1, 2022 and 2023, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 11.3 million and 12.0 million shares, respectively, pursuant to these provisions. As of July 31, 2024 , we had reserved a total of 42.4 million shares for the issuance of equity awards under the Stock Plans, of which 20.0 million shares were still available for grant. On August 1, 2024, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 13.3 million shares pursuant to the automatic increase provisions. Restricted Stock Units RSUs settle into shares of Class A common stock upon vesting. During the second quarter of fiscal 2024, we began funding withholding taxes due on the vesting of employee RSUs by net share settlement, rather than our previous approach of selling shares of Class A common stock to cover taxes upon vesting of such awards. The payment of the withheld taxes to the tax authorities is reflected as a financing activity within the consolidated statements of cash flows. Performance RSUs From time to time, we grant RSUs that have both service and performance conditions to our executives and employees ("PRSUs"). Vesting of PRSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of PRSUs are subject to the performance conditions actually being met. In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.3 million RSUs subject to certain performance conditions ("PRSUs") to our President and CEO. These PRSUs have a grant date fair value per unit of $ 45.86 and will vest up to 200 % based on achievement of specified annual recurring revenue and free cash flow hurdles over a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date. Market Stock Units We also grant RSUs that have both service and market-based conditions to our executives and employees ("MSUs"). Vesting of MSUs is subject to continuous service and the satisfaction of certain market-based performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which the service condition has been satisfied, regardless of achievement of the specified targets, the actual vesting and settlement of MSUs are subject to the market-based conditions actually being met. During fiscal 2022, 2023 and 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.7 million, 1.3 million and 0.8 million, respectively, RSUs subject to certain market conditions to certain of our executives. These MSUs have a weighted average grant date fair value per unit of approximately $ 46.80 , $ 27.89 and $ 47.65 , respectively, and will vest up to 200 % of the target number of MSUs based upon our total shareholder return relative to the total shareholder return of companies in the Nasdaq Composite Index over a performance period of approximately 2.8 years, 3.1 years and 3.0 years, respectively, subject to continuous service on each vesting date. In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.2 million MSUs to our President and CEO. These MSUs have a weighted average grant date fair value of $ 62.85 and will vest up to 200 % based on achievement of specified stock price hurdles at any time during a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date. Below is a summary of RSU activity and PRSU and MSU (collectively, "PSU") activity under the Stock Plans: RSUs PSUs Number of Weighted Average Number of Weighted Average (in thousands) (in thousands) Outstanding at July 31, 2021 20,423 $ 30.83 1,285 $ 33.35 Granted 14,921 $ 30.33 654 $ 46.80 Released ( 9,160 ) $ 32.57 ( 466 ) $ 34.96 Forfeited ( 5,308 ) $ 32.27 ( 213 ) $ 39.48 Outstanding at July 31, 2022 20,876 $ 29.34 1,260 $ 38.71 Granted 16,045 $ 19.25 1,339 $ 27.89 Released ( 9,938 ) $ 27.28 ( 314 ) $ 34.07 Forfeited ( 4,169 ) $ 26.36 ( 325 ) $ 30.08 Outstanding at July 31, 2023 22,814 $ 23.69 1,960 $ 33.49 Granted 9,850 $ 34.22 1,396 $ 49.82 Released ( 10,844 ) $ 25.76 ( 796 ) $ 25.25 Forfeited ( 1,959 ) $ 25.73 ( 246 ) $ 45.15 Outstanding at July 31, 2024 19,861 $ 27.58 2,314 $ 44.94 The aggregate grant date fair value of RSUs, including PSUs, vested was $ 314.6 million, $ 281.8 million and $ 299.5 million for the fiscal years ended July 31, 2022, 2023 and 2024, respectively. Stock Options Our Board of Directors determines the period over which stock options become exercisable and stock options generally vest over a four-year period. Stock options generally expire 10 years from the date of grant. The term of an ISO grant to a 10% stockholder will not exceed five years from the date of the grant. The exercise price of an ISO will not be less than 100 % of the estimated fair value of the shares of common stock underlying the stock option (or 110 % of the estimated fair value in the case of an ISO granted to a 10% stockholder) on the date of grant. The exercise price of an NSO is determined by our Board of Directors at the time of grant and is generally not less than 100 % of the estimated fair value of the shares of common stock underlying the stock option on the date of grant. Below is a summary of stock option activity under the Stock Plans: Fiscal Year Ended July 31, 2023 2024 Number of Weighted Weighted Aggregate Number of Weighted Weighted Aggregate (in thousands) (in years) (in thousands) (in thousands) (in years) (in thousands) Outstanding at beginning of period 1,689 $ 6.43 1.9 $ 14,707 1,046 $ 6.83 1.1 $ 24,451 Options granted — $ — — $ — Options exercised ( 643 ) $ 5.76 ( 788 ) $ 5.38 Options canceled/forfeited — $ — — $ — Outstanding at end of period 1,046 $ 6.83 1.1 $ 24,451 258 $ 11.26 0.7 $ 10,138 Exercisable at end of period 1,046 $ 6.83 1.1 $ 24,451 258 $ 11.26 0.7 $ 10,138 The aggregate intrinsic value of stock options exercised during the fiscal years ended July 31, 2022, 2023 and 2024 was $ 35.0 million, $ 12.1 million and $ 37.8 million, respectively. Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of our common stock. Cash received from option exercises was $ 6.5 million, $ 3.7 million and $ 4.2 million for the fiscal years ended July 31, 2022, 2023 and 2024 , respectively. The total grant date fair value of stock options vested was not material for the fiscal year ended July 31, 2022. There were no stock options that vested during the fiscal years ended July 31, 2023 or 2024. We did no t grant any stock options during the fiscal years ended July 31, 2022, 2023 or 2024. Employee Stock Purchase Plan In December 2015, our Board of Directors adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. Our stockholders subsequently approved amendments to the Original 2016 ESPP in December 2019 and December 2022 (as amended, the "2016 ESPP"). Under the 2016 ESPP, the maximum number of shares of Class A common stock available for sale is 13.8 million shares. The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to 15 % of eligible compensation, subject to caps of $ 25,000 in any calendar year and 1,000 shares on any purchase date. The 2016 ESPP provides for 12-month offering periods, generally beginning in March and September of each year, and each offering period consists of two six-month purchase periods. On each purchase date, participating employees will purchase Class A common stock at a price per share equal to 85 % of the lesser of the fair market value of our Class A common stock on (i) the first trading day of the applicable offering period or (ii) the last trading day of each purchase period in the applicable offering period. If the stock price of our Class A common stock on any purchase date in an offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period. During the fiscal year ended July 31, 2024 , 1.9 million shares of common stock were purchased under the 2016 ESPP for an aggregate amount of $ 47.3 million. As of July 31, 2024 , 10.7 million shares were available for future issuance under the 2016 ESPP. We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Fiscal Year Ended July 31, 2022 2023 2024 Expected term (in years) 0.81 0.74 0.78 Risk-free interest rate 1.0 % 4.3 % 5.1 % Volatility 43.3 % 59.8 % 47.2 % Dividend yield — % — % — % Stock-Based Compensation Total stock-based compensation expense recognized in our consolidated statements of operations is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Cost of revenue: Product $ 7,379 $ 7,966 $ 6,822 Support, entitlements and other services 30,846 26,611 27,285 Sales and marketing 104,592 82,758 80,190 Research and development 143,759 139,073 156,784 General and administrative 56,670 55,337 62,752 Total stock-based compensation expense $ 343,246 $ 311,745 $ 333,833 As of July 31, 2024 , unrecognized stock-based compensation expense related to outstanding stock awards was approximately $ 553.8 million and is expected to be recognized over a weighted average period of approximately 2.3 years.

Restructuring Charges

Restructuring Charges	12 Months Ended
	Jul. 31, 2024
Restructuring Charges [Abstract]
Restructuring Charges	NOTE 10. RESTRUCTURING CHARGES In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represented approximately 4 % of our total employees , following a review of our business structure and after taking other cost-cutting measures to reduce expenses. This headcount reduction was part of our efforts to drive toward profitable growth. As of July 31, 2024 , we recognized total restructuring charges of approximately $ 16.3 million, which consisted primarily of one-time severance and other termination benefit costs directly related to this reduction in force. Of the approximately $ 16.3 million recognized, $ 0.4 million is included within support, entitlements and other services cost of revenue, $ 13.4 million is included within sales and marketing expense, $ 2.3 million is included within research and development expense, and $ 0.2 million is included within general and administrative expense on our consolidated statements of operations. During the fiscal year ended July 31, 2023, we recognized restructuring charges of approximately $ 5.3 million and made cash payments of approximately $ 15.8 million. During the fiscal year ended July 31, 2024 , we did no t incur any charges and made cash payments of approximately $ 0.4 million. As of July 31, 2024 , we had no remaining restructuring liability.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	NOTE 11. NET INCOME (LOSS) PER SHARE We adopted ASU 2020-06 on August 1, 2021 using the modified retrospective method, applicable to our convertible senior notes outstanding as of adoption. We have not changed any previously disclosed amounts or provided additional disclosures for comparative periods. ASU 2020-06 requires the if-converted method to be applied for all convertible instruments when calculating diluted earnings per share. Under the if-converted method, shares related to our convertible senior notes, to the extent dilutive, are assumed to be converted into common stock at the beginning of the period. Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include shares issuable upon the exercise of stock options, the vesting of RSUs, each purchase under the 2016 ESPP, and common stock issuable upon the conversion of convertible debt under the if-converted method. In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded. Effective January 3, 2022, all of our then outstanding shares of Class B common stock, par value $ 0.000025 per share, were automatically converted into the same number of shares of the Company’s Class A common stock, par value $ 0.000025 per share, pursuant to the terms of our Amended and Restated Certificate of Incorporation. Prior to this conversion, the rights, including the liquidation and dividend rights, of the holders of our Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, our undistributed earnings or losses were allocated on a proportionate basis among the holders of both Class A and Class B common stock. As a result, the net income (loss) per share attributed to common stockholders was the same for both Class A and Class B common stock on an individual or combined basis. The computation of basic and diluted net loss per share attributable to common stockholders is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands, except per share data) Numerator: Net loss $ ( 798,946 ) $ ( 254,560 ) $ ( 124,775 ) Denominator: Weighted average shares, basic and diluted 220,529 233,247 244,743 Net loss per share attributable to common $ ( 3.62 ) $ ( 1.09 ) $ ( 0.51 ) The following shares of common stock were excluded from the computation of diluted net loss per share for the periods presented, as their effect would have been antidilutive: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Outstanding stock options and RSUs 23,825 25,820 22,433 Employee stock purchase plan 2,511 1,122 1,148 Common stock issuable upon the conversion of convertible 39,968 38,700 39,423 Total 66,304 65,642 63,004 Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Common stock issuable upon the conversion of convertible notes represents the antidilutive impact of the 2023 Notes, 2026 Notes and 2027 Notes under the if-converted method.

Income Taxes

Income Taxes	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 12. INCOME TAXES Income Taxes Loss before provision for income taxes by fiscal year consisted of the following: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Domestic $ ( 834,915 ) $ ( 294,093 ) $ ( 167,745 ) Foreign 55,233 60,508 66,427 Loss before provision for income taxes $ ( 779,682 ) $ ( 233,585 ) $ ( 101,318 ) Provision for income taxes by fiscal year consisted of the following: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Current: U.S. federal $ 13 $ ( 568 ) $ — State and local 77 623 2,052 Foreign 21,578 21,952 23,925 Total current taxes 21,668 22,007 25,977 Deferred: U.S. federal 23 24 24 State and local — — — Foreign ( 2,427 ) ( 1,056 ) ( 2,544 ) Total deferred taxes ( 2,404 ) ( 1,032 ) ( 2,520 ) Provision for income taxes $ 19,264 $ 20,975 $ 23,457 The income tax provision differs from the amount of income tax determined by applying the applicable U.S. federal statutory income tax rate of 21 % to pre-tax loss. The reconciliation of the statutory federal income tax and our effective income tax is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) U.S. federal income tax at statutory rate $ ( 163,734 ) $ ( 49,053 ) $ ( 21,277 ) Change in valuation allowance 117,588 71,157 115,826 Non-deductible item on fair value remeasurement of 41,589 — — Stock-based compensation 14,462 8,767 ( 47,632 ) Effect of foreign operations 10,544 ( 4,896 ) ( 2,553 ) Research and development tax credits ( 9,455 ) ( 17,500 ) ( 30,076 ) Non-deductible expenses 6,646 5,090 4,704 Change in unrecognized tax benefit 655 1,840 2,840 State income taxes 77 623 2,052 Tax impact of Frame divestiture — 4,569 — Other 892 378 ( 427 ) Total $ 19,264 $ 20,975 $ 23,457 During the fiscal years ended July 31, 2022, 2023 and 2024, our provision for income taxes was primarily attributable to foreign tax provisions in certain foreign jurisdictions in which we conduct business. The temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows: As of July 31, 2023 2024 (in thousands) Deferred tax assets: Net operating loss carryforward $ 606,483 $ 532,559 Tax credit carryforward 229,429 292,546 Capitalized research expenses 128,169 241,194 Deferred revenue 175,975 179,093 Leases 28,587 35,416 Accruals and reserves 23,631 25,065 Stock-based compensation 17,028 17,221 Intangibles and goodwill 8,499 8,447 Property and equipment 4,043 4,302 Interest expense carryforward 5,166 — Other assets 24,347 22,631 Total deferred tax assets 1,251,357 1,358,474 Deferred tax liabilities: Deferred commission expense ( 84,421 ) ( 84,409 ) Leases ( 30,153 ) ( 36,100 ) Prepaid expenses ( 1,966 ) ( 2,249 ) Intangibles and goodwill ( 1,258 ) ( 1,394 ) Property and equipment ( 1,362 ) ( 1,359 ) Convertible notes ( 31,207 ) — Other ( 11,808 ) ( 14,075 ) Total deferred tax liabilities ( 162,175 ) ( 139,586 ) Valuation allowance ( 1,078,355 ) ( 1,205,780 ) Net deferred tax assets $ 10,827 $ 13,108 Management believes that based on available evidence, both positive and negative, it is more likely than not that the U.S. deferred tax assets will not be utilized and as such, a full valuation allowance has been recorded. The valuation allowance for deferred tax assets was $ 1.2 billion as of July 31, 2024. The net increase in the total valuation allowance for the fiscal years ended July 31, 2023 and 2024 was $ 75.8 million and $ 127.4 million, respectively. As of July 31, 2024 , we had approximately $ 2.4 billion of federal net operating loss carryforwards and $ 1.6 billion of state net operating loss carryforwards available to reduce future taxable income, which will begin to expire in fiscal 2024. In addition, we had approximately $ 177.1 million of federal research credit carryforwards, $ 131.3 million of state research credit carryforwards and $ 48.2 million of foreign tax credit carryforwards available to reduce future tax liability. The federal credits will begin to expire in fiscal 2030 and the state credits can be carried forward indefinitely. The foreign credits will begin to expire in fiscal 2029. Utilization of the net operating loss and tax credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization. If an ownership change occurred, utilization of the net operating loss and tax credit carryforwards could be significantly reduced. As of July 31, 2024 , we held an aggregate of $ 299.9 million in cash and cash equivalents in our foreign subsidiaries, of which $ 137.5 million was denominated in U.S. dollars. We attribute net revenue, costs and expenses to domestic and foreign components based on the terms of our agreements with our subsidiaries. We do not provide for federal income taxes on the undistributed earnings of our foreign subsidiaries, as such earnings are to be reinvested offshore indefinitely. It is not practical to estimate the withholding tax liability if these earnings were to be repatriated. We recognize uncertain tax positions in our financial statements if that position will more likely than not be sustained on audit, based on the technical merits of the position. A reconciliation of our unrecognized tax benefits, excluding accrued interest and penalties, is as follows: Fiscal Year Ended July 31, 2023 2024 (in thousands) Balance at the beginning of the year $ 90,673 $ 95,862 Increases related to current year tax positions 4,635 7,595 Increases related to prior year tax positions 1,616 425 Decreases related to prior year tax positions ( 29 ) ( 932 ) Lapse of statute of limitations/Settlements/Other ( 1,033 ) ( 303 ) Balance at the end of the year $ 95,862 $ 102,647 During the fiscal year ended July 31, 2024, the net increase in unrecognized tax positions was primarily attributable to federal and state research and development credits and intercompany charges. As of July 31, 2024 , if uncertain tax positions are fully recognized in the future, it would result in a $ 17.1 million impact to our effective tax rate, primarily relating to positions in foreign jurisdictions, and the remaining amount would result in adjustments to deferred tax assets and corresponding adjustments to the valuation allowance. We recognize interest and/or penalties related to income tax matters as a component of income tax expense. As of July 31, 2024 , we had recognized $ 9.5 million of accrued interest and penalties related to uncertain tax positions. We file income tax returns in the U.S. federal jurisdiction as well as various U.S. states and foreign jurisdictions. The tax years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. These fiscal years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized. We are subject to the continuous examination of income tax returns by various tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the provision for income taxes. We believe that adequate amounts have been reserved for any adjustments that may ultimately result from these examinations. We do not anticipate a significant impact to the gross unrecognized tax benefits within the next 12 months related to these years.

Segment Information

Segment Information	12 Months Ended
	Jul. 31, 2024
Segment Reporting [Abstract]
Segment Information	NOTE 13. SEGMENT INFORMATION Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment. The following table sets forth revenue by geographic location based on bill-to location: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) U.S. $ 887,141 $ 1,039,294 $ 1,189,213 Europe, the Middle East and Africa 374,186 471,367 563,281 Asia Pacific 274,373 309,138 348,952 Other Americas 45,096 43,096 47,370 Total revenue $ 1,580,796 $ 1,862,895 $ 2,148,816 The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, 2023 2024 (in thousands) United States $ 78,404 $ 102,873 International 33,461 33,307 Total long-lived assets $ 111,865 $ 136,180

Overview and Summary of Signi_2

Overview and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the previously outstanding 2.50% convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Risk	Concentration of Risk Credit Risk — Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. We invest only in high-quality credit instruments and maintain our cash and cash equivalents and available-for-sale investments in fixed income securities. Management believes that the financial institutions that hold our investments are financially sound and, accordingly, are subject to minimal credit risk. Our deposits are with multiple institutions, however such deposits may exceed federally insured limits. We provide credit, in the normal course of business, to a number of companies and perform credit evaluations of our customers. Concentration of Revenue and Accounts Receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the fiscal years ended July 31, 2022, 2023 and 2024 , no end customer accounted for more than 10 % of total revenue or accounts receivable. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Fiscal Year Ended July 31, July 31, July 31, Partners 2022 2023 2024 Partner A (1) (1) (1) (1) 16 % Partner B 33 % 32 % 31 % 17 % 12 % Partner C 15 % 16 % 16 % 19 % 10 % Partner D (1) (1) (1) 11 % (1) Partner E 11 % 10 % 11 % (1) (1) (1) Less than 10%
Cash, Cash Equivalents and Short-Term Investments	Cash, Cash Equivalents and Short-Term Investments We classify all highly liquid investments with original maturities of three months or less from the date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation as of each balance sheet date. We classify and account for our marketable securities as available-for-sale securities. We classify our marketable securities with stated maturities greater than twelve months as short-term investments due to our intent and ability to use these securities to support our current operations. Our marketable securities are recorded at their estimated fair value. Unrealized gains or losses on available-for-sale securities are reported in other comprehensive income (loss). We periodically review whether our securities may be other-than-temporarily impaired, including whether or not (i) we have the intent to sell the security or (ii) it is more likely than not that we will be required to sell the security before its anticipated recovery. If one of these factors is met, we will record an impairment loss associated with our impaired investment. The impairment loss will be recorded as a write-down of investments in our consolidated balance sheets and a realized loss within other expense in our consolidated statements of operations.
Fair Value Measurement	Fair Value Measurement We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all assets and liabilities that are recognized or disclosed at fair value in our consolidated financial statements on a recurring basis. The carrying amounts reported in our consolidated financial statements for cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their fair values due to their short-term nature. The fair value of the previously outstanding 0 % convertible senior notes due 2023 (the "2023 Notes") was determined based on the closing trading price per $ 100 of the 2023 Notes as of the last day of trading for the period. The fair value of the previously outstanding 2.50% convertible senior notes due 2026 was determined based on a binomial model. The fair value of the outstanding 0.25% convertible senior notes due 2027 (the "2027 Notes") is determined based on the closing trading price per $ 100 of the 2027 Notes as of the last day of trading for the period.
Convertible Senior Notes	Convertible Senior Notes Our convertible senior notes, including any embedded conversion features, are accounted for under the traditional convertible debt accounting model and are treated as a liability, net of unamortized issuance costs. The carrying amount of the liability is classified as a current liability if we have committed to settle with current assets; otherwise, it is classified as a long-term liability, as we retain the option to settle conversion requests in shares of our Class A common stock. The embedded conversion features are not remeasured as long as they do not meet the separation requirement of a derivative; otherwise, they are classified as derivative instruments and accounted for as such. Issuance costs are amortized to interest expense using the effective interest rate method over the term of the notes. In accounting for a holder’s exercise in accordance with a note’s original conversion terms of a conversion option for which the carrying amount has previously been reclassified to equity, any unamortized discount remaining at the date of conversion is first recognized as interest, and then the remaining carrying amount of the converted notes is reduced by the cash transferred and then recognized in equity to reflect the shares issued, such that no gain or loss is recognized. In accounting for extinguishments of the notes, the reacquisition price of the extinguished notes is compared to the carrying amount of the respective extinguished notes and a gain or loss is recorded in other expense, net on our consolidated statements of operations.
Derivative Liability	Derivative Liability We evaluate convertible notes or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity. The result of this accounting guidance could result in the fair value of a financial instrument being classified as a derivative instrument and recorded at fair market value at each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded on our consolidated statements of operations as other income or other expense. Once the criteria for conversion is fixed, the derivative instrument is marked to fair value and reclassified to equity.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations of our customers and maintain an allowance for credit losses. The allowance for credit losses is based on the best estimate of the amount of probable credit losses in existing accounts receivable. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations (e.g., bankruptcy filings or substantial downgrading of credit ratings), we record an allowance for credit losses in order to reduce the net recognized receivable to the amount we reasonably believe will be collected. For all other customers, we record an allowance for credit losses based on the length of time the receivable is past due and our historical experience of collections and write-offs. The changes in the allowance for credit losses are as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Allowance for credit losses—beginning balance $ 892 $ 644 $ 733 Charged to allowance for credit losses 200 212 830 Recoveries ( 80 ) ( 123 ) — Write-offs ( 368 ) — ( 791 ) Allowance for credit losses—ending balance $ 644 $ 733 $ 772
Property and Equipment	Property and Equipment Property and equipment, including leasehold improvements, are stated at cost, less accumulated depreciation and amortization. We include the cost to acquire demonstration units and the related accumulated depreciation in property and equipment as such units are generally not available for sale. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the related assets.
Leases	Leases We determine if an arrangement is or contains a lease at inception by evaluating various factors, including whether a vendor’s right to substitute an identified asset is substantive. Lease classification is determined at the lease commencement date when the leased assets are made available for our use. Operating leases are included in operating lease right-of-use assets, operating lease liabilities—current and operating lease liabilities—non-current in our consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other current liabilities and other liabilities—non-current in our consolidated balance sheets. Right-of-use assets ("ROU assets") represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist primarily of fixed payments under the arrangement, less any lease incentives, such as rent holidays. Variable lease payments not dependent on an index or a rate are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance, property taxes and utilities. We use an estimate of our incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. In determining the appropriate IBR, we consider information including, but not limited to, our credit rating, the lease term and the currency in which the arrangement is denominated. For leases which commenced prior to our adoption of Accounting Standards Update ("ASU") 2016-02, Leases ("ASC 842"), we used the IBR as of August 1, 2019. Our lease terms may include renewal options, which are not included in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Lease costs are recognized on a straight-line basis as operating expenses within our consolidated statements of operations. We present lease payments within cash flows from operations within our consolidated statements of cash flows. For our operating leases, we account for lease and non-lease components as a single lease component. Additionally, we do not record leases on our consolidated balance sheet that have a lease term of 12 months or less at the lease commencement date.
Goodwill, Intangible Assets and Other Long-Lived Assets	Goodwill, Intangible Assets and Other Long-Lived Assets Goodwill represents the future economic benefits arising from other assets acquired in a business combination or an acquisition that are not individually identified and separately recorded. The excess of the purchase price over the estimated fair value of net assets of businesses acquired in a business combination is recognized as goodwill. Intangible assets consist of identifiable intangible assets, including developed technology, customer relationships and trade names, resulting from business combinations. Finite-lived intangible assets are recorded at fair value, net of accumulated amortization. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense is included as a component of cost of product revenue and sales and marketing expense in our consolidated statements of operations. Amounts included in sales and marketing expense relate to customer relationships and trade names. Goodwill and other intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead tested for impairment at least annually, as of May 1 of each year. Such goodwill and other intangible assets may also be tested for impairment between annual tests in the presence of impairment indicators such as, but not limited to: (i) a significant adverse change in legal factors or in the business climate; (ii) a substantial decline in our market capitalization; (iii) an adverse action or assessment by a regulator; (iv) unanticipated competition; (v) loss of key personnel; (vi) a more likely-than-not expectation of the sale or disposal of a reporting unit or a significant portion thereof; (vii) a realignment of our resources or restructuring of our existing businesses in response to changes to industry and market conditions; (viii) testing for recoverability of a significant asset group within a reporting unit; or (ix) a higher discount rate used in the impairment analysis as impacted by an increase in interest rates. Goodwill is tested for impairment by comparing the reporting unit's carrying value, including goodwill, to the fair value of the reporting unit. We operate under one reporting unit and for our annual goodwill impairment test, we determine the fair value of our reporting unit based on our enterprise value. We may elect to utilize a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If, after assessing the qualitative factors, we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying value, an impairment analysis will be performed. We compare the fair value of our reporting unit with its carrying amount and if the carrying value of the reporting unit exceeds its fair value, an impairment loss will be recognized. Long-lived assets, such as property and equipment and finite-lived intangible assets subject to depreciation and amortization, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Among the factors and circumstances we consider in determining recoverability are: (i) a significant decrease in the market price of a long-lived asset; (ii) a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; (iii) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, including an adverse action or assessment by a regulator; (iv) an accumulation of costs significantly in excess of the amount originally expected for the acquisition; and (v) current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. There have been no indicators of impairment of goodwill, intangible assets or other long-lived assets and we did not record any material impairment losses during fiscal 2022, 2023 or 2024 .
Revenue Recognition	Revenue Recognition The core principle of ASC 606 is to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. This principle is achieved by applying the following five-step approach: • Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer. • Identification of the performance obligations in the contract — Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we apply judgment to determine whether promised goods or services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. • Determination of the transaction price — The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer. • Allocation of the transaction price to the performance obligations in the contract — If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP, taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. • Recognition of revenue when, or as, performance obligations are satisfied — We satisfy performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied with the transfer of a promised good or service to a customer. For additional details on revenue recognition, refer to Note 2 of Notes to Consolidated Financial Statements. Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative SSP basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations. Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. The balance of unbilled accounts receivable, included in accounts receivable, net on our consolidated balance sheets, was $ 16.3 million and $ 41.1 million as of July 31, 2023 and 2024, respectively. Our customers are typically invoiced upfront, including invoices for multi-year subscriptions, with payment terms of 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectability of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2023 and 2024 is presented in the accompanying consolidated balance sheets. Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in our consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in our consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle, and other factors. Deferred costs are periodically reviewed for impairment. Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our consolidated statements of operations. Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertains to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet date. Cost of Revenue Cost of revenue consists of cost of product revenue and cost of support, entitlements and other services revenue. Personnel costs associated with our operations and global customer support organizations consist of salaries, benefits and stock-based compensation. Allocated costs consist of certain facilities, depreciation and amortization, recruiting, and information technology costs, allocated based on headcount.
Warranties	Warranties We generally provide a one-year warranty on hardware sold by us and a 90-day warranty on software licenses. The hardware warranty provides for parts replacement for defective components and the software warranty provides for bug fixes. With respect to the hardware warranty obligation, we have a warranty agreement with our contract manufacturers under which the OEMs are generally required to replace defective hardware within three years of shipment. Furthermore, our post-contract customer support ("PCS") agreements provide for the same parts replacement that customers are entitled to under the warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to the customers’ critical business applications. Substantially all customers purchase PCS agreements. Given the warranty agreement with our OEMs and considering that substantially all products are sold together with PCS agreements, we generally have very limited exposure related to warranty costs and therefore no warranty reserve has been recognized.
Research and Development	Research and Development Our research and development expense consists primarily of product development personnel costs, including salaries and benefits, stock-based compensation and allocated facilities, IT, and recruiting costs. Research and development costs are expensed as incurred. Currently, we expense the software development costs incurred in the research and development of new products and enhancements to existing products as incurred, as from the inception of the product development, our software products are primarily intended to be marketed and sold to customers on-premises, either standalone and/or with other product offerings.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation expense is measured based on the grant date fair value of share-based awards. The fair value of the purchase rights under our 2016 Employee Stock Purchase Plan ("2016 ESPP") is estimated using the Black-Scholes-Merton ("Black-Scholes") option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates, and expected dividend yield. The fair value of restricted stock units ("RSUs") is determined using the fair value of our common stock on the date of grant. The fair value of awards with a market-based condition is measured using a Monte Carlo simulation, which requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We grant stock awards with service conditions only and with both service and performance or market-based conditions. We recognize stock-based compensation expense for employee stock awards with a service condition only using the straight-line method over the requisite service period of the awards, which is generally the vesting period. We use the graded vesting attribution method to recognize stock-based compensation expense related to employee stock awards that contain both service and performance or market-based conditions. The fair value of the 2016 ESPP purchase rights is recognized as expense on a straight-line basis over the offering period. We account for forfeitures of all share-based awards when they occur.
Foreign Currency	Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured at the average exchange rate in effect during the reporting period. At the end of each reporting period all monetary assets and liabilities of our subsidiaries are remeasured at the current U.S. dollar exchange rate at the end of the reporting period. Remeasurement gains and losses are included within other expense, net in our consolidated statements of operations. During the fiscal years ended July 31, 2022, 2023 and 2024 , we recognized foreign currency losses of $ 3.2 million, $ 1.6 million and $ 4.3 million, respectively. To date, we have not undertaken any hedging transactions related to foreign currency exposure, but we may do so in the future if our exposure to foreign currency should become more significant. As our international operations grow, we will continue to reassess our approach to managing our risk relating to fluctuations in currency rates.
Segments	Segments Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group allocates resources and assesses financial performance based upon discrete financial information at the consolidated level. Accordingly, we have determined that we operate as a single operating and reportable segment.
Income Taxes	Income Taxes We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance on amounts that are more likely than not to be realized. We record a liability for uncertain tax positions if it is not more likely than not to be sustained based solely on its technical merits as of the reporting date. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.
Advertising Costs	Advertising Costs Advertising costs are charged to sales and marketing expense as incurred in our consolidated statements of operations. During the fiscal years ended July 31, 2022, 2023 and 2024 , advertising expense was $ 13.7 million, $ 11.6 million and $ 14.7 million, respectively.
Frame Divestiture	Frame Divestiture In May 2023, we sold our Frame Desktop-as-a-Service business. As consideration for the sale, the buyer paid $ 7.0 million in cash, adjusted by increases for the closing cash balance of the Frame business and the amount by which the closing working capital exceeded the working capital target and reductions for closing expenses, the amount by which the closing working capital target exceeded the working capital, and any severance expenses associated with Frame employees who were terminated at or following the close of the transaction at the direction of the buyer, and a $ 5.0 million interest-bearing convertible note, which had a fair value of $ 5.7 million as of the closing date of the transaction. The fair value of all consideration received exceeded the carrying amount of the Frame business upon closing, resulting in a gain of $ 11.0 million, which is included within other expense, net in our consolidated statement of operations for the fiscal year ended July 31, 2023.
Recently Issued and Not Yet Adopted Accounting Pronouncements	Recently Issued and Not Yet Adopted Accounting Pronouncements In December 2023, the Financial Accounting Standards Board issued accounting standards update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides for improvements to income tax disclosures. The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact this new standard will have on our disclosures.

Overview and Summary of Signi_3

Overview and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Schedules of Concentration of Revenue and Accounts Receivable	For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Fiscal Year Ended July 31, July 31, July 31, Partners 2022 2023 2024 Partner A (1) (1) (1) (1) 16 % Partner B 33 % 32 % 31 % 17 % 12 % Partner C 15 % 16 % 16 % 19 % 10 % Partner D (1) (1) (1) 11 % (1) Partner E 11 % 10 % 11 % (1) (1) (1) Less than 10%
Schedule of Changes in Allowance for Credit Losses	The changes in the allowance for credit losses are as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Allowance for credit losses—beginning balance $ 892 $ 644 $ 733 Charged to allowance for credit losses 200 212 830 Recoveries ( 80 ) ( 123 ) — Write-offs ( 368 ) — ( 791 ) Allowance for credit losses—ending balance $ 644 $ 733 $ 772

Revenue, Deferred Revenue and_2

Revenue, Deferred Revenue and Deferred Commissions (Tables)	12 Months Ended
	Jul. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Revenue by Arrangement, Disclosure	The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Subscription $ 1,433,773 $ 1,730,848 $ 2,016,776 Professional services 91,744 91,841 100,852 Other non-subscription product (1) 55,279 40,206 31,188 Total revenue $ 1,580,796 $ 1,862,895 $ 2,148,816 (1) Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation.
Deferred Revenue, by Arrangement, Disclosure	Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2022 $ 1,445,538 $ 367,590 Additions (1) 2,012,389 187,381 Revenue/commissions recognized ( 1,862,895 ) ( 196,980 ) Balance as of July 31, 2023 1,595,032 357,991 Additions (1) 2,426,490 218,876 Revenue/commissions recognized ( 2,148,816 ) ( 218,056 ) Balance as of July 31, 2024 $ 1,872,706 $ 358,811 (1) Includes both billed and unbilled amounts.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured on Recurring Basis	The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 211,319 $ — $ — $ 211,319 U.S. Government securities — 6,999 — 6,999 Commercial paper — 34,830 — 34,830 Short-term investments: Corporate bonds — 452,703 — 452,703 Commercial paper — 215,219 — 215,219 U.S. Government securities — 256,544 — 256,544 Total measured at fair value $ 211,319 $ 966,295 $ — $ 1,177,614 Cash 259,781 Total cash, cash equivalents and short-term investments $ 1,437,395 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,700 $ 5,700 As of July 31, 2024 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 352,295 $ — $ — $ 352,295 U.S. Government securities — 99 — 99 Commercial paper — 1,747 — 1,747 Short-term investments: Corporate bonds — 233,065 — 233,065 Commercial paper — 33,770 — 33,770 U.S. Government securities — 72,237 — 72,237 Total measured at fair value $ 352,295 $ 340,918 $ — $ 693,213 Cash 301,129 Total cash, cash equivalents and short-term investments $ 994,342 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,150 $ 5,150 The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2023 As of July 31, 2024 Carrying Estimated Carrying Estimated (in thousands) 2026 Notes $ 649,630 $ 1,043,889 $ — $ — 2027 Notes 568,535 497,410 570,073 631,178 Total $ 1,218,165 $ 1,541,299 $ 570,073 $ 631,178

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date	The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 209,076 Due in one to three years 129,996 Total $ 339,072
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consists of the following: As of July 31, 2023 2024 (in thousands) Prepaid operating expenses $ 84,998 $ 62,815 VAT receivables 5,954 8,017 Other current assets 56,135 26,475 Total prepaid expenses and other current assets $ 147,087 $ 97,307
Schedule of Property and Equipment, Net	Property and equipment, net consists of the following: Estimated As of July 31, Useful Life 2023 2024 (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 381,140 $ 421,559 Demonstration units 12 60,985 59,570 Leasehold improvements (1) 64,667 64,607 Software (2) 9,238 29,014 Furniture and fixtures 60 16,132 16,169 Total property and equipment, gross 532,162 590,919 Less: accumulated depreciation ( 420,297 ) ( 454,739 ) Total property and equipment, net $ 111,865 $ 136,180 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. (2) The estimated useful life of software ranges from 36 to 120 months, representing the period during which the software is expected to contribute, either directly or indirectly, to our future cash flows.
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consists of the following: As of July 31, 2023 2024 (in thousands) Developed technology $ 78,267 $ 79,838 Customer relationships 8,860 11,230 Trade name 4,170 4,200 Total intangible assets, gross 91,297 95,268 Less: Accumulated amortization of developed technology ( 73,411 ) ( 76,804 ) Accumulated amortization of customer relationships ( 8,823 ) ( 9,111 ) Accumulated amortization of trade name ( 4,170 ) ( 4,200 ) Total accumulated amortization ( 86,404 ) ( 90,115 ) Total intangible assets, net $ 4,893 $ 5,153 Amortization expense related to our intangible assets is recognized in our consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name. The changes in the net book value of intangible assets, net are as follows: As of July 31, 2023 2024 (in thousands) Intangible assets, net—beginning balance $ 15,829 $ 4,893 Amortization of intangible assets (1) ( 10,697 ) ( 3,709 ) Acquisition of intangible assets — 3,969 Divestiture of Frame intangible assets ( 239 ) — Intangible assets, net—ending balance $ 4,893 $ 5,153 (1) Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense .
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2025 $ 2,540 2026 777 2027 777 2028 353 2029 353 Thereafter 353 Total $ 5,153
Schedule of Goodwill	Goodwill The changes in the carrying amount of goodwill are as follows: Carrying Amount (in thousands) Balance at July 31, 2022 $ 185,260 Adjustment for Frame divestiture ( 322 ) Balance at July 31, 2023 184,938 Adjustment for acquisition 297 Balance at July 31, 2024 $ 185,235
Schedule of Accrued Liabilities	Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, 2023 2024 (in thousands) Accrued commissions and taxes $ 36,882 $ 40,714 Payroll taxes payable 17,427 31,797 Accrued vacation 24,840 26,772 Contributions to ESPP withheld 10,145 24,676 Accrued bonus 16,404 17,863 Accrued benefits 12,391 16,580 Accrued wages and taxes 11,485 16,255 Retirement 401(k) payable 1,915 701 Other 12,190 20,244 Total accrued compensation and benefits $ 143,679 $ 195,602 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consists of the following: As of July 31, 2023 2024 (in thousands) Income taxes payable $ 2,185 $ 1,927 Accrued professional services 1,978 2,004 Litigation settlement reserves 71,000 — Software usage liability 11,248 — Other 22,858 21,036 Total accrued expenses and other current liabilities $ 109,269 $ 24,967 The decrease in accrued expenses and other current liabilities from July 31, 2023 to July 31, 2024 was due primarily to the release of the litigation settlement reserve related to the settlement of two securities class actions, which was agreed to in February 2023 but paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 7. In addition, we released the software usage liability related to the completed Audit Committee investigation, as we settled with the vendor.

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	12 Months Ended
	Jul. 31, 2024
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2023 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Interest expense related to amortization of debt issuance 844 248 —
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2026 Notes consisted of the following: As of July 31, 2023 2024 (in thousands) Principal amounts: Principal $ 750,000 $ — Non-cash interest expense converted to principal 47,569 — Unamortized debt discount (conversion feature) (1) ( 132,769 ) — Unamortized debt issuance costs (1) ( 15,170 ) — Net carrying amount $ 649,630 $ — (1) Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate was 7.05 % .
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2026 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Interest expense related to amortization of debt discount $ 34,180 $ 36,668 $ 35,955 Interest expense related to amortization of debt issuance 3,906 4,189 4,107 Non-cash interest expense 19,270 19,757 18,550 Interest expense related to conversion of 2026 Notes — — 107,877 Total interest expense $ 57,356 $ 60,614 $ 166,489
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2027 Notes consisted of the following: As of July 31, 2023 2024 (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 6,465 ) ( 4,927 ) Net carrying amount $ 568,535 $ 570,073 (1) Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2027 Notes: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Contractual interest expense $ 1,229 $ 1,720 $ 1,352 Interest expense related to amortization of debt issuance 1,302 1,530 1,538 Total interest expense $ 2,531 $ 3,250 $ 2,890

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Assets and Liabilities, Lessee	Supplemental balance sheet information related to our leases is as follows: As of July 31, 2023 2024 (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 181,226 $ 180,843 Accumulated amortization ( 87,672 ) ( 71,710 ) Operating lease right-of-use assets, net $ 93,554 $ 109,133 Operating lease liabilities—current $ 29,567 $ 24,163 Operating lease liabilities—non-current 68,940 90,359 Total operating lease liabilities $ 98,507 $ 114,522 Weighted average remaining lease term (in years): 5.0 4.8 Weighted average discount rate: 6.1 % 6.4 % As of July 31, 2023 2024 (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 18,279 $ 19,345 Accumulated amortization (1) ( 5,558 ) ( 9,412 ) Finance lease right-of-use assets , net (1) $ 12,721 $ 9,933 Finance lease liabilities—current (2) $ 3,518 $ 3,954 Finance lease liabilities—non-current (3) 9,722 6,666 Total finance lease liabilities $ 13,240 $ 10,620 Weighted average remaining lease term (in years): 3.7 2.9 Weighted average discount rate: 6.8 % 7.0 % (1) Included in our consolidated balance sheets within property and equipment, net. (2) Included in our consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in our consolidated balance sheets within other liabilities—non-current.
Supplemental Cash Flow and Other Information Related to Leases	Supplemental cash flow and other information related to our leases is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 48,509 $ 46,886 $ 37,973 Operating cash flows from finance leases $ — $ — $ 885 Financing cash flows from finance leases $ 1,089 $ 4,757 $ 3,601 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ 55,797 $ 10,358 $ 46,153 Finance leases $ 4,529 $ 7,827 $ 1,066
Lessee Operating and Finance Lease, Liability, Maturity	The undiscounted cash flows for our lease liabilities as of July 31, 2024 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2025 $ 30,125 $ 4,576 $ 34,701 2026 26,064 3,874 29,938 2027 23,780 2,164 25,944 2028 22,968 1,152 24,120 2029 17,252 41 17,293 Thereafter 13,985 — 13,985 Total lease payments 134,174 11,807 145,981 Less: imputed interest ( 19,652 ) ( 1,187 ) ( 20,839 ) Total lease obligation 114,522 10,620 125,142 Less: current lease obligations ( 24,163 ) ( 3,954 ) ( 28,117 ) Long-term lease obligations $ 90,359 $ 6,666 $ 97,025

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Schedule of Stock by Class	As of July 31, 2024, we had reserved shares of common stock for future issuance as follows: As of July 31, 2024 (in thousands) Shares reserved for future equity grants 19,964 Shares underlying outstanding stock options 258 Shares underlying outstanding restricted stock units 22,175 Shares reserved for future employee stock purchase plan awards 10,747 Total 53,144

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of RSUs Activity	Below is a summary of RSU activity and PRSU and MSU (collectively, "PSU") activity under the Stock Plans: RSUs PSUs Number of Weighted Average Number of Weighted Average (in thousands) (in thousands) Outstanding at July 31, 2021 20,423 $ 30.83 1,285 $ 33.35 Granted 14,921 $ 30.33 654 $ 46.80 Released ( 9,160 ) $ 32.57 ( 466 ) $ 34.96 Forfeited ( 5,308 ) $ 32.27 ( 213 ) $ 39.48 Outstanding at July 31, 2022 20,876 $ 29.34 1,260 $ 38.71 Granted 16,045 $ 19.25 1,339 $ 27.89 Released ( 9,938 ) $ 27.28 ( 314 ) $ 34.07 Forfeited ( 4,169 ) $ 26.36 ( 325 ) $ 30.08 Outstanding at July 31, 2023 22,814 $ 23.69 1,960 $ 33.49 Granted 9,850 $ 34.22 1,396 $ 49.82 Released ( 10,844 ) $ 25.76 ( 796 ) $ 25.25 Forfeited ( 1,959 ) $ 25.73 ( 246 ) $ 45.15 Outstanding at July 31, 2024 19,861 $ 27.58 2,314 $ 44.94
Schedule of Stock Option Activity	Below is a summary of stock option activity under the Stock Plans: Fiscal Year Ended July 31, 2023 2024 Number of Weighted Weighted Aggregate Number of Weighted Weighted Aggregate (in thousands) (in years) (in thousands) (in thousands) (in years) (in thousands) Outstanding at beginning of period 1,689 $ 6.43 1.9 $ 14,707 1,046 $ 6.83 1.1 $ 24,451 Options granted — $ — — $ — Options exercised ( 643 ) $ 5.76 ( 788 ) $ 5.38 Options canceled/forfeited — $ — — $ — Outstanding at end of period 1,046 $ 6.83 1.1 $ 24,451 258 $ 11.26 0.7 $ 10,138 Exercisable at end of period 1,046 $ 6.83 1.1 $ 24,451 258 $ 11.26 0.7 $ 10,138
Schedule of ESPP Valuation Assumptions	We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Fiscal Year Ended July 31, 2022 2023 2024 Expected term (in years) 0.81 0.74 0.78 Risk-free interest rate 1.0 % 4.3 % 5.1 % Volatility 43.3 % 59.8 % 47.2 % Dividend yield — % — % — %
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	Total stock-based compensation expense recognized in our consolidated statements of operations is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Cost of revenue: Product $ 7,379 $ 7,966 $ 6,822 Support, entitlements and other services 30,846 26,611 27,285 Sales and marketing 104,592 82,758 80,190 Research and development 143,759 139,073 156,784 General and administrative 56,670 55,337 62,752 Total stock-based compensation expense $ 343,246 $ 311,745 $ 333,833

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The computation of basic and diluted net loss per share attributable to common stockholders is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands, except per share data) Numerator: Net loss $ ( 798,946 ) $ ( 254,560 ) $ ( 124,775 ) Denominator: Weighted average shares, basic and diluted 220,529 233,247 244,743 Net loss per share attributable to common $ ( 3.62 ) $ ( 1.09 ) $ ( 0.51 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following shares of common stock were excluded from the computation of diluted net loss per share for the periods presented, as their effect would have been antidilutive: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Outstanding stock options and RSUs 23,825 25,820 22,433 Employee stock purchase plan 2,511 1,122 1,148 Common stock issuable upon the conversion of convertible 39,968 38,700 39,423 Total 66,304 65,642 63,004

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Loss before provision for income taxes by fiscal year consisted of the following: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Domestic $ ( 834,915 ) $ ( 294,093 ) $ ( 167,745 ) Foreign 55,233 60,508 66,427 Loss before provision for income taxes $ ( 779,682 ) $ ( 233,585 ) $ ( 101,318 )
Schedule of Components of Income Tax Expense (Benefit)	Provision for income taxes by fiscal year consisted of the following: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) Current: U.S. federal $ 13 $ ( 568 ) $ — State and local 77 623 2,052 Foreign 21,578 21,952 23,925 Total current taxes 21,668 22,007 25,977 Deferred: U.S. federal 23 24 24 State and local — — — Foreign ( 2,427 ) ( 1,056 ) ( 2,544 ) Total deferred taxes ( 2,404 ) ( 1,032 ) ( 2,520 ) Provision for income taxes $ 19,264 $ 20,975 $ 23,457
Schedule of Effective Income Tax Rate Reconciliation	The income tax provision differs from the amount of income tax determined by applying the applicable U.S. federal statutory income tax rate of 21 % to pre-tax loss. The reconciliation of the statutory federal income tax and our effective income tax is as follows: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) U.S. federal income tax at statutory rate $ ( 163,734 ) $ ( 49,053 ) $ ( 21,277 ) Change in valuation allowance 117,588 71,157 115,826 Non-deductible item on fair value remeasurement of 41,589 — — Stock-based compensation 14,462 8,767 ( 47,632 ) Effect of foreign operations 10,544 ( 4,896 ) ( 2,553 ) Research and development tax credits ( 9,455 ) ( 17,500 ) ( 30,076 ) Non-deductible expenses 6,646 5,090 4,704 Change in unrecognized tax benefit 655 1,840 2,840 State income taxes 77 623 2,052 Tax impact of Frame divestiture — 4,569 — Other 892 378 ( 427 ) Total $ 19,264 $ 20,975 $ 23,457
Schedule of Deferred Tax Assets and Liabilities	The temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows: As of July 31, 2023 2024 (in thousands) Deferred tax assets: Net operating loss carryforward $ 606,483 $ 532,559 Tax credit carryforward 229,429 292,546 Capitalized research expenses 128,169 241,194 Deferred revenue 175,975 179,093 Leases 28,587 35,416 Accruals and reserves 23,631 25,065 Stock-based compensation 17,028 17,221 Intangibles and goodwill 8,499 8,447 Property and equipment 4,043 4,302 Interest expense carryforward 5,166 — Other assets 24,347 22,631 Total deferred tax assets 1,251,357 1,358,474 Deferred tax liabilities: Deferred commission expense ( 84,421 ) ( 84,409 ) Leases ( 30,153 ) ( 36,100 ) Prepaid expenses ( 1,966 ) ( 2,249 ) Intangibles and goodwill ( 1,258 ) ( 1,394 ) Property and equipment ( 1,362 ) ( 1,359 ) Convertible notes ( 31,207 ) — Other ( 11,808 ) ( 14,075 ) Total deferred tax liabilities ( 162,175 ) ( 139,586 ) Valuation allowance ( 1,078,355 ) ( 1,205,780 ) Net deferred tax assets $ 10,827 $ 13,108
Schedule of Unrecognized Tax Benefits Roll Forward	A reconciliation of our unrecognized tax benefits, excluding accrued interest and penalties, is as follows: Fiscal Year Ended July 31, 2023 2024 (in thousands) Balance at the beginning of the year $ 90,673 $ 95,862 Increases related to current year tax positions 4,635 7,595 Increases related to prior year tax positions 1,616 425 Decreases related to prior year tax positions ( 29 ) ( 932 ) Lapse of statute of limitations/Settlements/Other ( 1,033 ) ( 303 ) Balance at the end of the year $ 95,862 $ 102,647

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Jul. 31, 2024
Segment Reporting [Abstract]
Schedule of Revenue by Geographic Area	The following table sets forth revenue by geographic location based on bill-to location: Fiscal Year Ended July 31, 2022 2023 2024 (in thousands) U.S. $ 887,141 $ 1,039,294 $ 1,189,213 Europe, the Middle East and Africa 374,186 471,367 563,281 Asia Pacific 274,373 309,138 348,952 Other Americas 45,096 43,096 47,370 Total revenue $ 1,580,796 $ 1,862,895 $ 2,148,816
Schedule of Long-lived Assets by Geographical Location	The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, 2023 2024 (in thousands) United States $ 78,404 $ 102,873 International 33,461 33,307 Total long-lived assets $ 111,865 $ 136,180

Overview and Summary of Signi_4

Overview and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	May 31, 2023	Sep. 30, 2021	Sep. 24, 2020	Jan. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairment losses	$ 0	$ 0	$ 0
Foreign currency transaction gain (loss), before tax	4,300	1,600	3,200
Advertising expense	14,700	11,600	$ 13,700
Proceeds from frame transaction				$ 7,000
Convertible note receivable				5,000
Fair value of the convertible note				5,700
Gain due to Increase in Carrying Amount				$ 11,000
Unbilled accounts receivable	$ 41,100	$ 16,300
Partner [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk percentage	10%	10%	10%
2023 Convertible Senior Notes | Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Closing trading price	$ 100
Interest rate, stated percentage	0%						0%
2026 Convertible Senior Notes | Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Interest rate, stated percentage						2.50%
2027 Convertible Senior Notes | Convertible Debt
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Closing trading price	$ 100
Interest rate, stated percentage					0.25%
ASU 2020-06
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted		true
Change in accounting principle, accounting standards update, immaterial effect		true
Hardware
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Product warranty duration	1 year
Product warranty replacement period (in years)	3 years
Software
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Product warranty duration	90 days

Overview and Summary of Signi_5

Overview and Summary of Significant Accounting Policies - Schedules of Concentration of Revenue and Accounts Receivable (Details) - Partner Concentration Risk	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Revenue | Partner B
Concentration Risk [Line Items]
Concentration risk percentage	31%	32%	33%
Revenue | Partner C
Concentration Risk [Line Items]
Concentration risk percentage	16%	16%	15%
Revenue | Partner E
Concentration Risk [Line Items]
Concentration risk percentage	11%	10%	11%
Accounts Receivable | Partner A
Concentration Risk [Line Items]
Concentration risk percentage	16%
Accounts Receivable | Partner B
Concentration Risk [Line Items]
Concentration risk percentage	12%	17%
Accounts Receivable | Partner C
Concentration Risk [Line Items]
Concentration risk percentage	10%	19%
Accounts Receivable | Partner D
Concentration Risk [Line Items]
Concentration risk percentage		11%

Overview and Summary of Signi_6

Overview and Summary of Significant Accounting Policies - Schedule of Changes in Allowance for Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses-beginning balance	$ 733	$ 644	$ 892
Charged to allowance for credit losses	830	212	200
Recoveries	0	(123)	(80)
Write-offs	(791)	0	(368)
Allowance for credit losses-ending balance	$ 772	$ 733	$ 644

Business Combinations - Prelimi

Business Combinations - Preliminary Aggregate Purchase Price Allocation (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 185,235	$ 184,938	$ 185,260

Revenue, Deferred Revenue and_3

Revenue, Deferred Revenue and Deferred Commissions - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 2,148,816	$ 1,862,895	$ 1,580,796
Amount deferred in prior period	$ 771,200	696,000
Percent expected to be recognized in next year	52%
Contracted revenue not recognized	$ 2,100,000
Ratable
Deferred Revenue Arrangement [Line Items]
Total revenue	1,000,000	905,800	770,400
Upfront
Deferred Revenue Arrangement [Line Items]
Total revenue	987,800	825,000	663,400
Non-portable software
Deferred Revenue Arrangement [Line Items]
Total revenue	27,900	37,400	49,700
Hardware Revenue
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 3,300	$ 2,800	$ 5,600
Minimum
Deferred Revenue Arrangement [Line Items]
Software, license term	1 year
Maximum
Deferred Revenue Arrangement [Line Items]
Software, license term	5 years

Revenue, Deferred Revenue and_4

Revenue, Deferred Revenue and Deferred Commissions - Revenue by Arrangement, Disclosure (Details) - USD ($) $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Condensed Income Statements, Captions [Line Items]
Total revenue		$ 2,148,816	$ 1,862,895	$ 1,580,796
Subscription
Condensed Income Statements, Captions [Line Items]
Total revenue		2,016,776	1,730,848	1,433,773
Professional services
Condensed Income Statements, Captions [Line Items]
Total revenue		100,852	91,841	91,744
Other non-subscription product
Condensed Income Statements, Captions [Line Items]
Total revenue	[1]	$ 31,188	$ 40,206	$ 55,279
[1] Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation.

Revenue, Deferred Revenue and_5

Revenue, Deferred Revenue and Deferred Commissions - Deferred Revenue, by Arrangement, Disclosure (Details) - USD ($) $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023
Movementin Deferred Commissions Roll Forward
Deferred commissions, beginning balance		$ 357,991	$ 367,590
Additions	[1]	218,876	187,381
Revenue/commissions recognized		(218,056)	(196,980)
Deferred commissions, ending balance		358,811	357,991
Deferred revenue, beginning balance		1,595,032	1,445,538
Additions	[1]	2,426,490	2,012,389
Revenue/commissions recognized		(2,148,816)	(1,862,895)
Deferred revenue, ending balance		$ 1,872,706	$ 1,595,032
[1] Includes both billed and unbilled amounts.

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Financial Assets:
Short-term investments:	$ 339,072	$ 924,466
Recurring
Financial Assets:
Total measured at fair value	693,213	1,177,614
Cash	301,129	259,781
Total cash, cash equivalents and short-term investments	994,342	1,437,395
Recurring | U.S. Government securities
Financial Assets:
Cash equivalents:	99	6,999
Short-term investments:	72,237	256,544
Recurring | Convertible note receivable
Financial Assets:
Assets, Noncurrent, Total	5,150	5,700
Recurring | Corporate bonds
Financial Assets:
Short-term investments:	233,065	452,703
Recurring | Commercial paper
Financial Assets:
Cash equivalents:	1,747	34,830
Short-term investments:	33,770	215,219
Recurring | Money market funds
Financial Assets:
Cash equivalents:	352,295	211,319
Recurring | Level I
Financial Assets:
Total measured at fair value	352,295	211,319
Recurring | Level I | U.S. Government securities
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level I | Convertible note receivable
Financial Assets:
Assets, Noncurrent, Total	0	0
Recurring | Level I | Corporate bonds
Financial Assets:
Short-term investments:	0	0
Recurring | Level I | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level I | Money market funds
Financial Assets:
Cash equivalents:	352,295	211,319
Recurring | Level II
Financial Assets:
Total measured at fair value	340,918	966,295
Recurring | Level II | U.S. Government securities
Financial Assets:
Cash equivalents:	99	6,999
Short-term investments:	72,237	256,544
Recurring | Level II | Convertible note receivable
Financial Assets:
Assets, Noncurrent, Total	0	0
Recurring | Level II | Corporate bonds
Financial Assets:
Short-term investments:	233,065	452,703
Recurring | Level II | Commercial paper
Financial Assets:
Cash equivalents:	1,747	34,830
Short-term investments:	33,770	215,219
Recurring | Level II | Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring | Level III
Financial Assets:
Total measured at fair value	0	0
Recurring | Level III | U.S. Government securities
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level III | Convertible note receivable
Financial Assets:
Assets, Noncurrent, Total	5,150	5,700
Recurring | Level III | Corporate bonds
Financial Assets:
Short-term investments:	0	0
Recurring | Level III | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level III | Money market funds
Financial Assets:
Cash equivalents:	$ 0	$ 0

Fair Value Measurements - Non-r

Fair Value Measurements - Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - Convertible Debt - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 570,073	$ 1,218,165
Reported Value Measurement | 2026 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	0	649,630
Reported Value Measurement | 2027 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	570,073	568,535
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	631,178	1,541,299
Estimate of Fair Value Measurement | 2026 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	0	1,043,889
Estimate of Fair Value Measurement | 2027 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 631,178	$ 497,410

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023	May 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of the convertible note				$ 5,700
Convertible note receivable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from interest-bearing convertible note		$ 5,000
Fair value of the convertible note		$ 5,200
2023 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Closing trading price		$ 100
2026 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt discounts	[1]	$ 0	$ (132,769)
Unamortized debt issuance costs	[1]	0	(15,170)
Non Cash Interest Expense Converted To Principal		0	47,569
2027 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unamortized debt issuance costs	[2]	$ (4,927)	$ (6,465)
Closing trading price		$ 100
[1] Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate was 7.05 % Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Derivative Liability (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Change in fair value of derivative liability	$ 0	$ 0	$ 198,038

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Due within one year	$ 209,076
Due in one to three years	129,996
Total	$ 339,072	$ 924,466

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid operating expenses	$ 62,815	$ 84,998
VAT receivables	8,017	5,954
Other current assets	26,475	56,135
Total prepaid expenses and other current assets	$ 97,307	$ 147,087

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jul. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross		$ 590,919	$ 532,162
Less: accumulated depreciation		(454,739)	(420,297)
Total property and equipment, net		$ 136,180	111,865
Computer, production, engineering and other equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life		36 months
Total property and equipment, gross		$ 421,559	381,140
Demonstration units
Property, Plant and Equipment [Line Items]
Estimated Useful Life		12 months
Total property and equipment, gross		$ 59,570	60,985
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	[1]	64,607	64,667
Software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	[2]	$ 29,014	9,238
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Useful Life		60 months
Total property and equipment, gross		$ 16,169	$ 16,132
[1] Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. The estimated useful life of software ranges from 36 to 120 months, representing the period during which the software is expected to contribute, either directly or indirectly, to our future cash flows.

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Property and Equipment, Net (Parenthetical) (Details) - Software	Jul. 31, 2024
Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life	120 months
Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life	36 months

Balance Sheet Components (Addit

Balance Sheet Components (Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Property, Plant and Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation	$ 65.6	$ 63.3	$ 69.3

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023
Finite-lived intangible assets:
Intangible assets, net—beginning balance		$ 4,893	$ 15,829
Amortization of intangible assets	[1]	(3,709)	(10,697)
Acquisition of intangible assets		3,969	0
Divestiture of Frame intangible assets		0	(239)
Intangible assets, net—ending balance		5,153	4,893
Less:
Accumulated amortization		(90,115)	(86,404)
Total intangible assets, gross		95,268	91,297
Developed technology
Finite-lived intangible assets:
Finite-lived intangible assets, gross		79,838	78,267
Less:
Accumulated amortization		(76,804)	(73,411)
Customer relationships
Finite-lived intangible assets:
Finite-lived intangible assets, gross		11,230	8,860
Less:
Accumulated amortization		(9,111)	(8,823)
Trade Names
Finite-lived intangible assets:
Finite-lived intangible assets, gross		4,200	4,170
Less:
Accumulated amortization		$ (4,200)	$ (4,170)
[1] Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense .

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Finite-lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Jul. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 2,540
2026	777
2027	777
2028	353
2029	353
Thereafter	353
Total	$ 5,153

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning Balance	$ 184,938	$ 185,260
Adjustment for Frame divestiture		(322)
Adjustment for acquisition	297
Ending Balance	$ 185,235	$ 184,938

Balance Sheet Components - Sc_8

Balance Sheet Components - Schedule of Accrued Compensation Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Employee-related Liabilities, Current [Abstract]
Accrued commissions and taxes	$ 40,714	$ 36,882
Payroll taxes payable	31,797	17,427
Accrued vacation	26,772	24,840
Contributions to ESPP withheld	24,676	10,145
Accrued bonus	17,863	16,404
Accrued benefits	16,580	12,391
Accrued wages and taxes	16,255	11,485
Retirement 401(k) payable	701	1,915
Other	20,244	12,190
Total accrued compensation and benefits	$ 195,602	$ 143,679

Balance Sheet Components - Sc_9

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Other Liabilities Disclosure [Abstract]
Income taxes payable	$ 1,927	$ 2,185
Accrued professional services	2,004	1,978
Litigation settlement reserves	0	71,000
Software Usage Liability	0	11,248
Other	21,036	22,858
Total accrued expenses and other current liabilities	$ 24,967	$ 109,269

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Details) $ / shares in Units, $ in Thousands, shares in Millions			1 Months Ended			12 Months Ended
	Jun. 06, 2024 USD ($)	Sep. 30, 2020 USD ($)	Jan. 31, 2023 USD ($)	Sep. 30, 2021 USD ($) PurchasePeriod $ / shares shares	Jan. 31, 2018 USD ($) $ / shares shares	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Sep. 22, 2021 USD ($)	Sep. 24, 2020 USD ($)
Debt Instrument [Line Items]
Proceeds from Hedge, Financing Activities						$ 0	$ 0	$ 39,880
Payments for unwinding of warrants						0	0	18,390
Loss on debt extinguishment						0	0	(64,910)
Proceeds from the issuance of convertible notes, net of issuance costs						$ 0	$ 0	88,687
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Payments for convertible note hedges					$ 143,200
Loss on debt extinguishment								$ 64,900
Number of securities called by warrants or rights (in shares) | shares					11.8
Exercise price of warrants (in dollars per share) | $ / shares					$ 73.46
Proceeds from issuance of warrants					$ 88,000
Convertible Debt | Cash Transaction
Debt Instrument [Line Items]
Repayments of debt			$ 145,700
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage					0%	0%
Face amount					$ 575,000
Convertible debt				$ 416,500
Conversion price (in dollars per share) | $ / shares					$ 48.85
Proceeds from Hedge, Financing Activities				39,900
Payments for unwinding of warrants				18,400
Debt outstanding									$ 145,700
Debt repurchase amount				12,800
Proceeds From Unwind Transactions				21,500
Convertible Debt | 2023 Convertible Senior Notes | Exchange Transactions
Debt Instrument [Line Items]
Face amount									416,500
Convertible Debt | 2023 Convertible Senior Notes | Cash Transaction
Debt Instrument [Line Items]
Debt repurchase amount									12,800
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage										2.50%
Face amount	$ 817,600	$ 750,000
Conversion ratio	16,900,000
Debt Instrument Conversion For Cash	$ 817,600
Proceeds from the issuance of convertible notes, net of issuance costs		723,700
Payments of debt issuance costs		$ 26,300
Derivative liability				$ 698,200						$ 230,900
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage				0.25%
Face amount				$ 575,000
Convertible debt				$ 477,300
Conversion ratio				17.3192
Conversion price (in dollars per share) | $ / shares				$ 57.74
Threshold trading days | PurchasePeriod				20
Threshold consecutive trading days | PurchasePeriod				30
Debt Instrument Issued For Cash Net Of Expense				$ 88,400
Debt repurchase amount				$ 14,700
Redemption price, percentage				100%
Debt Instrument Issued For Cash				$ 97,700
Debt instrument, term						3 years 2 months 12 days
Debt instrument, principal amount for conversion into common stock				$ 1,000
Convertible Debt | 2027 Convertible Senior Notes | Exchange Transactions
Debt Instrument [Line Items]
Face amount									$ 477,300
Minimum | Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger				130%
Common Class A | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Number of securities called by warrants or rights (in shares) | shares					11.8
Common Class A | Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Debt repurchase amount				$ 58,500
Stock Repurchase Program, Number of Shares Authorized to be Repurchased | shares				1.4
Common Class A | Maximum | Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger				98%

Convertible Senior Notes - Net

Convertible Senior Notes - Net Proceeds from Notes (Details) - 2023 Convertible Senior Notes $ in Millions	1 Months Ended
	Jan. 31, 2018 USD ($)
Debt Instrument [Line Items]
Less: cost of the bond hedges	$ (143.2)
Add: proceeds from the sale of warrants	$ 88

Convertible Senior Notes - Comp

Convertible Senior Notes - Components of Debt (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jul. 31, 2023	Sep. 30, 2021
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount				$ 1,000
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount		$ 0	$ 750,000
Non-cash interest expense converted to principal		0	47,569
Unamortized debt discount (conversion feature)	[1]	0	(132,769)
Unamortized debt issuance costs	[1]	0	(15,170)
Net carrying amount		0	649,630
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount		575,000	575,000
Unamortized debt issuance costs	[2]	(4,927)	(6,465)
Net carrying amount		$ 570,073	$ 568,535
[1] Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate was 7.05 % Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Convertible Senior Notes - Co_2

Convertible Senior Notes - Components of Notes (Parenthetical) (Details) - Convertible Debt	Jul. 31, 2024
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	7.05%
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.52%

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense Recognized (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Debt Instrument [Line Items]
Non-cash interest expense	$ 18,550	$ 19,757	$ 19,270
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt issuance costs	0	248	844
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt discount	35,955	36,668	34,180
Interest expense related to amortization of debt issuance costs	4,107	4,189	3,906
Non-cash interest expense	18,550	19,757	19,270
Interest Expense related to Conversion of 2026 Notes attributable to debt discount and issuance costs	107,877	0	0
Total interest expense	166,489	60,614	57,356
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Contractual Interest Expense	1,352	1,720	1,229
Interest expense related to amortization of debt issuance costs	1,538	1,530	1,302
Total interest expense	$ 2,890	$ 3,250	$ 2,531

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease, cost	$ 38.6	$ 42.4	$ 43.3
Finance lease, cost	4.8	3.9	2.4
Operating lease early exit expenses		$ 1.7	$ 0.6
Lease not yet commenced, undiscounted amount	$ 2.3
Lease not yet commenced, term of contract	1 year
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	6 years

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jul. 31, 2023
Operating Leases
Operating lease right-of-use assets, gross		$ 180,843	$ 181,226
Accumulated amortization		(71,710)	(87,672)
Operating lease right-of-use assets, net		109,133	93,554
Operating lease liabilities—current		24,163	29,567
Operating lease liabilities—non-current		90,359	68,940
Total operating lease liabilities		$ 114,522	$ 98,507
Weighted average remaining lease term (in years)		4 years 9 months 18 days	5 years
Weighted average discount rate:		6.40%	6.10%
Finance leases
Finance lease right-of-use assets, gross	[1]	$ 19,345	$ 18,279
Accumulated amortization	[1]	(9,412)	(5,558)
Finance lease right-of-use assets, net	[1]	9,933	12,721
Finance lease liabilities-current	[2]	3,954	3,518
Finance lease liabilities-non-current	[3]	6,666	9,722
Total lease obligation		$ 10,620	$ 13,240
Weighted average remaining lease term (in years)		2 years 10 months 24 days	3 years 8 months 12 days
Weighted average discount rate		7%	6.80%
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]		Liabilities	Liabilities
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]		Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accrued Liabilities, Current	Accrued Liabilities, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
[1] Included in our consolidated balance sheets within property and equipment, net. Included in our consolidated balance sheets within accrued expenses and other current liabilities. Included in our consolidated balance sheets within other liabilities—non-current.

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow and Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Leases [Abstract]
Operating cash flows from operating leases	$ 37,973	$ 46,886	$ 48,509
Operating cash flows from finance leases	885	0	0
Financing cash flows from finance leases	3,601	4,757	1,089
Lease liabilities arising from obtaining right-of-use assets from operating leases	46,153	10,358	55,797
Lease liabilities arising from obtaining right-of-use assets from finance leases	$ 1,066	$ 7,827	$ 4,529

Leases - Remaining Maturity Und

Leases - Remaining Maturity Under Topic 842 (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jul. 31, 2023
Operating Leases
2025		$ 30,125
2026		26,064
2027		23,780
2028		22,968
2029		17,252
Thereafter		13,985
Total lease payments		134,174
Less: imputed interest		(19,652)
Total operating lease liabilities		114,522	$ 98,507
Less: current lease obligations		(24,163)	(29,567)
Long-term lease obligations		90,359	68,940
Finance leases
2025		4,576
2026		3,874
2027		2,164
2028		1,152
2029		41
Thereafter		0
Total financing lease payments		11,807
Less: imputed interest		(1,187)
Total lease obligation		10,620	13,240
Less: current lease obligations	[1]	(3,954)	(3,518)
Long-term lease obligations	[2]	6,666	$ 9,722
Total
2025		34,701
2026		29,938
2027		25,944
2028		24,120
2029		17,293
Thereafter		13,985
Total lease payments		145,981
Less: imputed interest		(20,839)
Total lease obligation		125,142
Less: current lease obligations		(28,117)
Long-term lease obligations		$ 97,025
[1] Included in our consolidated balance sheets within accrued expenses and other current liabilities. Included in our consolidated balance sheets within other liabilities—non-current.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2023	Jul. 31, 2024	Jun. 30, 2023	Feb. 28, 2023
Additional Information (Details) [Line Items]
Litigation Settlement Reserves				$ 71
Settlement funds deposited in escrow			$ 31.1
Amounts recoverable under insurance policies	$ 39.9
Legal fees	$ 38.7
Non-contract Vendors
Additional Information (Details) [Line Items]
Purchase obligation		$ 110.6
Contract Manufacturer
Additional Information (Details) [Line Items]
Purchase obligation		$ 85.2

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Jul. 31, 2024 USD ($) Class Vote $ / shares shares	Jul. 31, 2023 USD ($) $ / shares shares	Jul. 31, 2022 USD ($)	Aug. 31, 2023 USD ($)	Jan. 03, 2022 $ / shares shares
Class of Stock [Line Items]
Number of Authorized Common Stock | Class		1
Payments for repurchase of common stock | $		$ 131,139	$ 0	$ 58,570
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.000025	$ 0.000025			$ 0.000025
Common stock, shares issued (in shares)		265,181,000	239,607,000
Common stock, shares outstanding (in shares)		265,181,000	239,607,000
Common stock number of votes per share | Vote		1
Stock repurchase program, authorized amount | $	$ 58,500				$ 350,000
Repurchase and retirement of common stock (in shares)	1,400,000	2,600,000
Stock repurchase price (in dollars per share) | $ / shares	$ 42.77	$ 50.77
Payments for repurchase of common stock | $	$ 97,700	$ 131,100
Stock repurchase program, remaining authorization amount | $		$ 218,900
Common Class B [Member]
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares						$ 0.000025
Common stock, shares issued (in shares)						0

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Sep. 30, 2016
Class of Stock [Line Items]
Shares underlying outstanding stock options (in shares)	258,000	1,046,000	1,689,000
Shares underlying outstanding restricted stock units, including MSUs	22,175,000
Shares reserved for future employee stock purchase plan awards	53,144,000
2016 Plan
Class of Stock [Line Items]
Shares reserved for future employee stock purchase plan awards	10,700,000
Employee Stock Purchase Plan
Class of Stock [Line Items]
Shares reserved for future employee stock purchase plan awards	10,747,000
Common Class A | 2016 Plan
Class of Stock [Line Items]
Share reserved for future equity grants (in shares)	19,964,000
Shares reserved for future employee stock purchase plan awards				22,400,000

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details)					1 Months Ended		12 Months Ended
	Aug. 01, 2024 shares	Aug. 01, 2023 shares	Aug. 01, 2022 shares	Dec. 13, 2019 USD ($) PurchasePeriod shares	Jan. 31, 2024 $ / shares shares	Sep. 30, 2016 shares	Jul. 31, 2024 USD ($) Plan $ / shares shares	Jul. 31, 2023 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							53,144,000
Options granted (in shares)							0	0	0
Stock option exercises in period, intrinsic value | $							$ 37,800,000	$ 12,100,000	$ 35,000,000
Proceeds from stock options exercised | $							4,200,000	3,700,000	6,500,000
RSUs including PSUs vested in period grant date fair value | $							299,500,000	281,800,000	314,600,000
Monetary cap | $				$ 25,000
Share cap (in shares)				1,000
Offering period duration (in months)				12 months
Number of six-month purchase periods | PurchasePeriod				2
Proceeds from sales of shares through employee equity incentive plans | $							51,571,000	$ 46,501,000	$ 67,826,000
Compensation not yet recognized | $							$ 553,800,000
Period for recognition (in years)							2 years 3 months 18 days
2016 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | Plan							1
Shares reserved for future issuance (in shares)							10,700,000
2010 Stock Plan and 2011 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of inactive equity incentive plans | Plan							2
Market Stock Units | President [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)					200,000
Granted (in dollars per share) | $ / shares					$ 62.85
Vesting percentage					200%
Award vesting period (in years)					3 years 7 months 6 days
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							10,747,000
Percent of eligible compensation (up to)				15%
Purchase price of common stock, percent				85%
ESPP stock issued during period (in shares)							1,900,000
Employee stock purchase plan | 2016 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from sales of shares through employee equity incentive plans | $							$ 47,300,000
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)							4 years
Expiration period (in years)							10 years
Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price, percent of estimated fair value							100%
Non-qualified Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price, percent of estimated fair value							100%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)							9,850,000	16,045,000	14,921,000
Granted (in dollars per share) | $ / shares							$ 34.22	$ 19.25	$ 30.33
Released (in dollars per share) | $ / shares							$ 25.76	$ 27.28	$ 32.57
RSUs | Market Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)							800,000	1,300,000	700,000
Granted (in dollars per share) | $ / shares							$ 47.65	$ 27.89	$ 46.8
Vesting percentage							200%
Award vesting period (in years)							3 years	3 years 1 month 6 days	2 years 9 months 18 days
RSUs | Performance Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)					300,000
Granted (in dollars per share) | $ / shares					$ 45.86
Vesting percentage					200%
Award vesting period (in years)					3 years 7 months 6 days
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)							42,400,000
Number of shares available for grant (in shares)							20,000,000
Common Class A | 2016 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)						22,400,000
Annual increase (in shares)						18,000,000
Annual increase, percent of outstanding shares						5%
Number of additional shares authorized (in shares)		12,000,000	11,300,000
Number of shares available for grant (in shares)							19,964,000
Common Class A | 2016 Plan | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)	13,300,000
Common Class A | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)										13,800,000
Principal Owner | Incentive Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)							5 years
Exercise price, percent of estimated fair value							110%

Equity Incentive Plans - RSU (D

Equity Incentive Plans - RSU (Details) - $ / shares shares in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Number of Shares
Outstanding, ending balance (in shares)	22,175
RSUs
Number of Shares
Outstanding, beginning balance (in shares)	22,814	20,876	20,423
Granted (in shares)	9,850	16,045	14,921
Released (in shares)	(10,844)	(9,938)	(9,160)
Forfeited (in shares)	(1,959)	(4,169)	(5,308)
Outstanding, ending balance (in shares)	19,861	22,814	20,876
Grant Date Fair Value per Share
Outstanding at beginning of period	$ 23.69	$ 29.34	$ 30.83
Granted (in dollars per share)	34.22	19.25	30.33
Released (in dollars per share)	25.76	27.28	32.57
Forfeited (in dollars per share)	25.73	26.36	32.27
Outstanding at end of period	$ 27.58	$ 23.69	$ 29.34
PSUs
Number of Shares
Outstanding, beginning balance (in shares)	1,960	1,260	1,285
Granted (in shares)	1,396	1,339	654
Released (in shares)	(796)	(314)	(466)
Forfeited (in shares)	(246)	(325)	(213)
Outstanding, ending balance (in shares)	2,314	1,960	1,260
Grant Date Fair Value per Share
Outstanding at beginning of period	$ 33.49	$ 38.71	$ 33.35
Granted (in dollars per share)	49.82	27.89	46.8
Released (in dollars per share)	25.25	34.07	34.96
Forfeited (in dollars per share)	45.15	30.08	39.48
Outstanding at end of period	$ 44.94	$ 33.49	$ 38.71

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Number of Shares
Outstanding at beginning of period (in shares)	1,046,000	1,689,000
Options granted (in shares)	0	0	0
Options exercised (in shares)	(788,000)	(643,000)
Options canceled/forfeited (in shares)	0	0
Outstanding at end of period (in shares)	258,000	1,046,000	1,689,000
Exercisable at end of period (in shares)	258,000	1,046,000
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 6.83	$ 6.43
Options granted (in dollars per share)	0	0
Options exercised (in dollars per share)	5.38	5.76
Options canceled/forfeited (in dollars per share)	0	0
Outstanding at end of period (in dollars per share)	11.26	6.83	$ 6.43
Exercisable at end of period (in dollars per share)	$ 11.26	$ 6.83
Additional Disclosures
Outstanding (in years)	8 months 12 days	1 year 1 month 6 days	1 year 10 months 24 days
Exercisable (in years)	8 months 12 days	1 year 1 month 6 days
Outstanding at beginning of period	$ 24,451	$ 14,707
Exercisable, intrinsic value	10,138	24,451
Outstanding at end of period	$ 10,138	$ 24,451	$ 14,707

Equity Incentive Plans - ESPP (

Equity Incentive Plans - ESPP (Details) - Employee stock purchase plan	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	9 months 10 days	8 months 26 days	9 months 21 days
Risk-free interest rate	5.10%	4.30%	1%
Volatility	47.20%	59.80%	43.30%
Dividend yield	0%	0%	0%

Equity Incentive Plans - Stoc_2

Equity Incentive Plans - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 333,833	$ 311,745	$ 343,246
Cost of revenue | Product
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	6,822	7,966	7,379
Cost of revenue | Support, Entitlements and Other Services
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	27,285	26,611	30,846
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	80,190	82,758	104,592
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	156,784	139,073	143,759
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 62,752	$ 55,337	$ 56,670

Restructuring Charges (Addition

Restructuring Charges (Additional Information) (Details) $ in Millions	1 Months Ended	12 Months Ended
	Aug. 31, 2022 Employee	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring description	In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represented approximately 4% of our total employees
Restructuring charges		$ 0	$ 5.3
Payments in cash for restructuring		0.4	$ 15.8
One-time severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 16.3
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		General and administrative
Employee
Restructuring Cost and Reserve [Line Items]
Number of employees reduced our global headcount | Employee	270
Number of employees reduced our global headcount, Percent	4%
Sales and marketing expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 13.4
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		General and administrative
Research And Development Expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 2.3
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		General and administrative
Support entitlements and other services cost of revenue
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 0.4
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		General and administrative
General and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 0.2
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		General and administrative

Net Income (Loss) Per Share - C

Net Income (Loss) Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss)		$ (124,775)	$ (254,560)	$ (798,946)
Weighted average shares -basic	[1]	244,743	233,247	220,529
Weighted average shares -diluted	[1]	244,743	233,247	220,529
Net loss per share attributable to common stockholders -basic	[1]	$ (0.51)	$ (1.09)	$ (3.62)
Net loss per share attributable to common stockholders -diluted	[1]	$ (0.51)	$ (1.09)	$ (3.62)
[1] Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 8 for further details.

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares shares in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	63,004	65,642	66,304
Outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	22,433	25,820	23,825
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,148	1,122	2,511
Common stock issuable upon the conversion of convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	39,423	38,700	39,968

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Antidilutive Securities (Additional Information) (Details) - $ / shares	Jul. 31, 2024	Jul. 31, 2023	Jan. 03, 2022
Common Class A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.000025	$ 0.000025	$ 0.000025
Common Class B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share			$ 0.000025

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Before Provision for Income Taxes, Domestic and Foreign (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Domestic	$ (167,745)	$ (294,093)	$ (834,915)
Foreign	66,427	60,508	55,233
Loss before provision for income taxes	$ (101,318)	$ (233,585)	$ (779,682)

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision for Income Taxes, Current and Deferred (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Current:
U.S. federal	$ 0	$ (568)	$ 13
State and local	2,052	623	77
Foreign	23,925	21,952	21,578
Total current taxes	25,977	22,007	21,668
Deferred:
U.S. federal	24	24	23
State and local	0	0	0
Foreign	(2,544)	(1,056)	(2,427)
Total deferred taxes	(2,520)	(1,032)	(2,404)
Provision for income taxes	$ 23,457	$ 20,975	$ 19,264

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Operating Loss Carryforwards [Line Items]
Federal statutory income tax rate	21%
Valuation allowance for deferred tax assets	$ 1,205,780	$ 1,078,355
Valuation allowance increase	127,400	$ 75,800
Research credit carryforwards	177,100
Unrecognized tax benefits that would impact effective tax rate	17,100
Cash and cash equivalents in foreign subsidiaries	299,900
Accrued interest and penalties	9,500
United States of America, Dollars
Operating Loss Carryforwards [Line Items]
Valuation allowance for deferred tax assets	1,200,000
Cash and cash equivalents in foreign subsidiaries	137,500
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	2,400,000
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,600,000
State | Research Credit Carryforwards
Operating Loss Carryforwards [Line Items]
Research credit carryforwards	131,300
Foreign Tax Authority | Foreign Tax Credit Carryforward Member
Operating Loss Carryforwards [Line Items]
Foreign Tax Credit Carryforward Amount	$ 48,200

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
U.S. federal income tax at statutory rate	$ (21,277)	$ (49,053)	$ (163,734)
Change in valuation allowance	115,826	71,157	117,588
Non-deductible item on fair value remeasurement derivative liability	0	0	41,589
Stock-based compensation	(47,632)	8,767	14,462
Effect of foreign operations	(2,553)	(4,896)	10,544
Research and development tax credits	(30,076)	(17,500)	(9,455)
Non-deductible expenses	4,704	5,090	6,646
Change in unrecognized tax benefit	2,840	1,840	655
State income taxes	2,052	623	77
Tax impact of Frame divestiture	0	4,569	0
Other	(427)	378	892
Provision for income taxes	$ 23,457	$ 20,975	$ 19,264

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Deferred tax assets:
Net operating loss carryforward	$ 532,559	$ 606,483
Tax credit carryforward	292,546	229,429
Capitalized research expenses	241,194	128,169
Deferred revenue	179,093	175,975
Leases	35,416	28,587
Accruals and reserves	25,065	23,631
Stock-based compensation	17,221	17,028
Intangible assets	8,447	8,499
Property and equipment	4,302	4,043
Interest expense carryforward	0	5,166
Other assets	22,631	24,347
Total deferred tax assets	1,358,474	1,251,357
Deferred tax liabilities:
Deferred commission expense	(84,409)	(84,421)
Leases	(36,100)	(30,153)
Prepaid expenses	(2,249)	(1,966)
Intangibles and goodwill	(1,394)	(1,258)
Property and equipment	(1,359)	(1,362)
Convertible notes	0	(31,207)
Other	(14,075)	(11,808)
Total deferred tax liabilities	(139,586)	(162,175)
Valuation allowance	(1,205,780)	(1,078,355)
Net deferred tax assets	$ 13,108	$ 10,827

Income Taxes - Schedule of Unre

Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at the beginning of the year	$ 95,862	$ 90,673
Increases related to current year tax positions	7,595	4,635
Increases related to prior year tax positions	425	1,616
Decreases related to prior year tax positions	(932)	(29)
Lapse of statute of limitations/Settlements	(303)	(1,033)
Balance at the end of the year	$ 102,647	$ 95,862

Segment Information - Schedule

Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 2,148,816	$ 1,862,895	$ 1,580,796
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	1,189,213	1,039,294	887,141
Europe, the Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	563,281	471,367	374,186
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	348,952	309,138	274,373
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 47,370	$ 43,096	$ 45,096

Segment Information - Additiona

Segment Information - Additional Information (Details)	12 Months Ended
	Jul. 31, 2024 Segment
Segment Reporting [Abstract]
Number of reportable segments	1

Segment Information - Schedul_2

Segment Information - Schedule of Sets Forth Long-Lived Assets Include Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 136,180	$ 111,865
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	102,873	78,404
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 33,307	$ 33,461